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Abstract 
The long non-coding RNA (lncRNA) Metastasis Associated Lung Adenocarcinoma Transcript 1 (Malat1) 
has been indicated to have a variety of cellular functions, from cancer cell growth and survival to 
regulating pre-mRNA splicing. In several Malat1 knockout (KO) models, Malat1 neighbouring genes 
showed significant expression changes, but these effects were not consistent across all Malat1 KO 
mouse models. This implies potential and tissue specific in cis regulation of these genes by Malat1. 
Here, we assessed if Malat1 regulated its surrounding genes in cis in CD4+ T cells, as previous 
experiments on these cells showed significant downregulation of Malat1 upon T cell activation. This 
was achieved by analysing primary naïve mouse CD4+ cells in vitro under Th0, Th1 and Th2 
differentiation conditions at two different time points. Our results showed significant expression 
changes in Neat1, Scyl1 and Map3k11 in Malat1 KO cells under specific activation conditions (e.g. 
naïve, 4 day Th0 and 6 day Th1 cultures). To assess the cell type specificity of these effect, mouse tail 
fibroblasts (MTFs) were isolated and analysed – only Scyl1 was differentially expressed in Malat1 KO 
MTFs. We also assessed potential in trans effects of Malat1. It has been shown that Malat1 binds the 
mRNA of several RNA binding proteins – amongst those, we found that Malat1 regulates U2af1 in 
specific CD4+ cell types. This data indicates that gene regulation in T helper cells by Malat1 does not 
occur uniformly across all subsets, but is dependent on the type and duration of activation. For the 
Malat1 neighbouring genes, this may be via transcription factors binding to the Malat1 locus and 
acting on nearby enhancer and promoter sequences.  
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Introduction 
Long non-coding RNAs 
In recent years, an increasing number of studies have highlighted the key role of non-coding RNAs, 
transcribed regions of the genome which are not protein coding, in genomic regulation (Carninci 
2009). In particular, long non-coding RNAs (lncRNAs), non-coding transcripts longer than 200bp, are 
increasingly considered to have key roles in both transcriptional and epigenetic regulation, such as 
protein complex assembly scaffolds, transcriptional coregulators or regulators of mRNA processing 
(Ernst and Morton 2013, Kung et al 2013). As this tremendous diversity of function makes it difficult 
to clearly classify lncRNAs, they are often categorised based upon their relative genomic location, such 
as genic or intergenic transcripts located less or more than 5kb from protein coding genes respectively 
(Luo et al 2016) and intronic or antisense transcripts located within introns or on opposing strands of 
other genes (Kung et al 2013). However, while these categories are commonly used by researchers, 
they are not necessarily related to the functions of the lncRNAs (Kung et al 2013).  
LncRNA regulatory functions can occur either in cis, directly mediating expression of neighbouring 
genes, or in trans, acting on distal genes and proteins. In cis regulation directly mediates expression 
of neighbouring genes through a variety of mechanisms, such as COLDAIR transcription targeting 
repressive chromatin modifications to the FLC locus during vernalisation, Tsix transcription directly 
inhibiting transcription of Xist or Xist binding to targets across the X chromosome to recruit repressive 
PRC2 to genomic loci (Heo and Sung 2011, Sado et al 2006, Brockdorff 2013). Conversely, in trans 
regulatory lncRNAs influence expression of genes on other chromosomes, acting either generally, such 
as inhibition of RNA polymerase 2 phosphorylation by the 7SK transcript to regulate transcriptional 
elongation, or specifically at certain loci, such as targeting of repressive chromatin markers to the 
HOXD cluster by the lncRNA HOTAIR (Peterlin et al 2012, Rin et al 2007). Though at present it is unclear 
which form of activity is more common among lncRNAs, some recent studies have suggested a greater 
prevalence of in cis regulatory functions among specific subsets of lncRNAs, with genic transcripts 
showing particularly strong association with in cis regulation (Yan et al 2017, Luo et al 2016). 
Malat1 
One of the most widely studied lncRNAs is Metastasis Associated Lung Adenocarcinoma Transcript 1 
(Malat1), an intergenic transcript around 6.9kb long transcribed from chromosome 19 in mice and 
chromosome 11 in humans (Wilusz et al 2008, Zhang et al 2012). Malat1 is processed from its initial 
transcript by RNAse P to produce both a small, cytoplasmic tRNA like sequence called mascRNA and 
the remaining Malat1 lncRNA, which is subsequently localised to alternative splicing factor clusters in 
11 
 
the nucleus known as nuclear speckles (Wilusz et al 2008, Hutchinson et al 2007). The lncRNA was 
originally identified in lung cancer cell lines, where it was found to be a strong predictor of tumour 
metastasis and survival (Ji et al 2003) and has since been found to be strongly associated with growth 
and proliferation of a variety of other cancer cell lines, including ovarian, colorectal and squamous cell 
tumours (Lin et al 2018, Yang et al 2015, Zhou et al 2015). As such, there has been considerable 
research into Malat1, looking both at proteins and RNAs which interact with Malat1 and at potential 
cellular functions for the transcript to determine the biological role of Malat1 (Engreitz et al 2014, 
Chen et al 2017).  
In addition to its apparent importance in cancer cell proliferation, Malat1 has several unusual features 
compared to other lncRNAs which have made it a target for the aforementioned functional studies. 
Firstly, the transcript is relatively stable, with the 3’ sequence containing an expression and nuclear 
retention element that promotes folding into a bipartite triple helix structure, protecting the 3’ end 
of the transcript from degradation by RNAses (Brown et al 2014). Furthermore, Malat1 has an 
unusually highly conserved primary sequence across 20 mammalian species, with analysis of 12 
different primate species identifying Malat1 as the most conserved sequence in a 120kb region and 
around 69% sequence identity observed between the human and mouse sequences (Ma et al 2015, Ji 
et al 2003, Figure 1). Finally, the lncRNA is very abundantly expressed across a range of tissues, and in 
some tissues is expressed at a level similar to some housekeeping genes, such as Actb and Gapdh (Ma 
et al 2015, Zhang et al 2012). Taken together, this high conservation, abundant expression and 
functional importance in cancer lines indicate that Malat1 has some key housekeeping function in 
normal cell biology, a possibility supported by some studies showing a strong association of Malat1 
with pre-mRNA splicing factors (Tripathi et al 2010, Engreitz et al 2014). 
 
Figure 1: Simplified diagram of the Malat1 locus and surrounding genes in the (A) human and (B) mouse 
genomes, showing approximate positions, directions of transcription and relative lengths of each gene 
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However, this apparent functional importance is contrasted by the results of 3 different papers 
generating Malat1 knockout (KO) mouse models by different methods (Zhang et al 2012, Nakagawa 
et al 2012, Eiβmann et al 2012), as none of these models showed any significant differences in growth, 
viability, fertility, histology or development compared to wild type. Furthermore, while one Malat1 
KO model showed significantly impaired metastasis of human lung and breast cancer lines (Arun et al 
2016), another displayed no significant effect of Malat1 KO on proliferation of A549 or HLE cancer 
lines, despite its association with growth and metastasis in both the A549 line and liver carcinoma cells 
in other studies (Eiβmann et al 2012, Gutschner et al 2013, Lai et al 2010). Additionally, while Malat1 
was indicated to have significant effects on pre-mRNA splicing in previous knockdown (KD) models, 
no significant differences in the number or localisation of nuclear speckles was observed in these KO 
models, nor any differences in the levels or phosphorylation status of pre-mRNA splicing factors 
associated with these structures (Zhang et al 2012, Nakagawa et al 2012, Tripathi et al 2010). Several 
explanations were proposed for these results, such as differing results from knockdown and knockout 
models, functional relevance only under abnormal conditions or functional compensation by other 
lncRNAs (Zhang et al 2012, Nakagawa et al 2012). The possibility of functional compensation seems 
likely, given the lack of significant Malat1 knockout effects on lung adenocarcinoma cells despite its 
strong associations with metastasis of such cancer lines (Eiβmann et al 2012, Ji et al 2003) – however, 
these possible solutions to the differences in Malat1 functional data are yet to be fully assessed. 
A notable result from Zhang et al (2012) was that, of 12 genes which showed significant expression 
changes in the KO’s, 5 were located immediately around the Malat1 locus, with a further 7 genes 
surrounding Malat1 showing significant expression changes upon further analysis of the knockouts. 
The paper interpreted this as transcription of Malat1 regulating these surrounding genes in cis, a 
theory consistent with a recently identified example of in cis regulation at the Malat1 locus by its 
antisense transcript Talam1 (Zong et al 2016). However, the data from the other knockout papers 
were inconsistent with this theory – though neither tested the same range of surrounding genes as 
Zhang et al (2012), Eiβmann et al (2012) found no significant change in Neat1 expression in the 
knockout cells, while Nakagawa et al (2012) observed significant downregulation of Neat1 with Malat1 
KO, rather than upregulation. While this may arise from the different systems of Malat1 KO used for 
each study, it may also be that this regulation of surrounding genes only occurs in specific cell types, 
given both that these papers used different tissue types for expression analysis of these surrounding 
genes and that Nakagawa et al (2012) observed significantly reduced Neat1 expression only occurring 
in specific Malat1 KO tissues. As such, this possible in cis regulation by Malat1 warrants further study.  
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CD4+ T cells 
Previous data from our research group (Hewitson et al, unpublished) indicated Malat1 to have some 
functional importance in CD4+ T cells, a subset of T-lymphocytes which have key functions in activation 
and regulation of adaptive immune responses through secretion of specific cytokines. CD4+ cells 
differentiate from naïve cells into a wide variety of subtypes with different immune functions, 
including Th1 cells, which mediate intracellular pathogen defence and some autoimmune diseases, 
Th2 cells, which regulate extracellular parasite responses and a number of allergic diseases, and Th17 
cells, a more recently identified line required for responses to extracellular bacteria and fungi (Kurts 
2007), with regulatory T cells (Tregs) acting to suppress immunopathological effects of these Th cells 
(Luckheeram et al 2012). Differentiation of these different CD4+ cell types is dependent on 
extracellular cytokine signalling, coordinating with T cell receptor (TCR) activation to trigger 
downstream signalling cascades which activate expression of different master regulators for each cell 
type, such as T-bet, GATA3 and RORγt for Th1, Th2 and Th17 cells respectively (Zhu et al 2010). These, 
in turn, promote inhibition of signalling pathways from other CD4+ cell types and stimulate the 
expression of distinct effector cytokines for their respective cell types, such as IFNγ in Th1 cells, IL-4, 
IL-5 and IL-13 in Th2 cells, IL-17 and IL-21 in Th17 cells and IL-35 and TGF-β in Tregs (Luckheeram et al 
2012). 
Given that numerous changes in histone and chromatin modifications have been identified during 
differentiation of these Th cell types, CD4+ differentiation has been proposed as an effective model 
for studying mechanisms of epigenetic regulation and their function in cell differentiation (Russ et al 
2013). This includes assessing lncRNA functions in T cell differentiation – although studies of these 
functions in both the general immune system and CD4+ T cells specifically have only recently begun, 
expression analysis of these Th cell types revealed expression of numerous intergenic lncRNA clusters 
to be highly specific to different stages of CD4+ differentiation and between the CD4+ subtypes, 
showing far greater cell type specificity than mRNAs (Hu et al 2013). Furthermore, many of these 
differentially expressed lncRNA genes were found to be located near lineage specific mRNA genes, 
with altered lncRNA expression shown to coincide with corresponding expression changes in nearby 
protein coding genes (Aune et al 2016, Xia et al 2014). This suggests in cis regulation of these genes 
by the lncRNAs, with several transcripts identified which were found to have functions in regulating 
CD4+ lineage specific genes on the same chromosome (Xia et al 2014, Aune et al 2016). Similarly, 
genome wide association studies have found robust immune cell expression of lncRNAs in loci strongly 
associated with autoimmune diseases, further highlighting the functional importance of lncRNAs in 
immune system and T cell signalling and function (Hrdlickova et al 2014). As such, CD4+ T cells are a 
key model for further studies of lncRNA functions, including functions and interactions of Malat1. 
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Hypothesis and aims 
Based on these results and the data on the genes surrounding Malat1 from Nakagawa et al (2012), 
and Zhang et al (2012), we hypothesise that Malat1 regulates surrounding genes in cis, potentially in 
a cell type specific manner. As such, this project aimed:  
1. To determine if immortalised cell lines could be used as a viable model instead of primary 
CD4+ T cells by comparing the effects of mitogenic stimulation of immortalised cell lines on 
Malat1 expression to previous CD4+ expression data on Malat1 (Hewitson et al, unpublished). 
2. To test for evidence of in cis regulation of neighbouring genes by Malat1 by comparing their 
expression in a model of wild type (Wt) and Malat1 knockout (KO) murine CD4+ T cells. 
3. To determine if any such regulation was cell type specific by assessing gene expression in 
mouse tail fibroblast (MTF) cultures for both genotypes. 
4. To assess if there was any evidence for in trans regulation by Malat1 in CD4+ T cells by 
comparing Wt and Malat1 KO expression levels of genes known to interact with Malat1. 
5. To test if Malat1 KO had any effect on the growth and proliferation of MTF cultures in order 
to compare any such effects to those observed in previous studies of Malat1 depleted cells. 
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Methods 
Malat1 knockout mice 
The Malat1 knockout cells used for this study were derived from the KO model developed by 
Nakagawa et al (2012). Briefly, a Malat1 targeting vector was used to insert a LacZ/PolyA cassette 
immediately downstream of the Malat1 transcriptional start site, thus preventing transcription of the 
Malat1 gene body from this site. Nakagawa et al (2012) showed effective knockout of Malat1 across 
numerous different tissues using this system, although low level residual expression of a 3.2kb 
transcript was observed in neuronal cells. This was suggested to be due to the knockout cassette 
triggering artificial activation of an internal promoter sequence within Malat1 in specific tissues, 
leading to transcription of a truncated lncRNA lacking the 5’ end of the transcript. Wt control mice 
were C57BL/6, and female mice aged 6-12 weeks were used for all experiments. 
Immortalised cell line culture 
Jurkat (ATCC TIB-152) and EL4 (ATCC TIB-39) cell lines were maintained in 25ml of complete CD4 media 
(1640 RPMI with 10% Fetal Calf Serum (FCS), 100units/ml Penicillin, 100µg/ml Streptomycin and 2mM 
L-Glutamine). To set up stimulated plates, the cells were counted and a suspension of 1x106 cells/ml 
set up and seeded onto 6 well plates at 1ml/well before being stimulated with either 5µg/ml 
Phytohaemagglutinin (PHA) and 1µg/ml Phorbol 12-Myristate 13-Acetate (PMA) for Jurkat cultures or 
various concentrations of Concavalin A (ConA) for EL4 (10, 5, 1 and 0.1 µg/ml). For the EL4 cultures, 
given that different concentrations of ConA were applied to test which would be best for any further 
EL4 cultures, 0.1µg/ml PHA was used as a positive control of T cell stimulation, as this mitogen had 
been shown by our experiments to successfully stimulate growth of Jurkat cells. N.B. These cell lines 
are not regularly validated, save for annual mycoplasma screening, and as such should be considered 
with some caution. 
EL4 culture 
treatment 
0.1µg/ml 
ConA 
1µg/ml 
ConA 
5µg/ml 
ConA 
10µg/ml 
ConA 
0.1µg/ml 
PMA 
Unstimulated 
control 
Concentration 
(ng/µl) 
465.1 592.3 322.5 72.1 112.4 467.4 
260:230 2.03 2.08 2.08 2.00 2.03 2.08 
260:280 0.61 0.81 1.66 0.57 0.51 1.98 
Table 1: Example of data from Nanodrop analysis of EL4 culture RNA samples 
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CD4+ T cell differentiation and culture 
In order to harvest and purify naïve primary mouse CD4+ cells (this was carried out by James 
Hewitson), spleen and lymph nodes (axillary, inguinal, brachial, mesenteric) were taken from groups 
of Wt and Malat1 KO mice (3 in each group) and used to create single cell suspensions by dissociation 
through a 70µm cell strainer. The suspensions were then centrifuged for 5 mins at 405x g, 
resuspended in 7ml Ammonium-Chloride-Potassium (ACK) lysing buffer to lyse red blood cells (5 mins, 
room temperature) and washed twice by centrifuging and resuspending in complete CD4 media, with 
cell counts performed using a haemocytometer and Trypan Blue (HyClone) to identify and exclude any 
dead cells. Following the second wash, the cells were incubated for 5 mins with 3µl CD4 microbeads 
(Miltenyi Biotech, L3T4) per 100 million cells, before being washed again and the CD4+ cells separated 
using Magnetic Activated Cell Sorting (MACS). This involved running the sample through a LS column 
(Miltenyi Biotech) placed in a MidiMACS cell separator (Miltenyi Biotech) to bind the microbeads and 
thus the CD4+ cells labelled with them, with the column subsequently washed 3 times with 5mls of 
complete CD4 media and removed from the magnetic separator. The CD4+ cell fraction was then 
eluted using 5ml of media, before being centrifuged and resuspended once more. 
These CD4+ cells were subsequently sorted using a MoFlo Astrios EQ cell sorter (Beckman Coulter) – 
following MACS enrichment, 85µg/ml rat IgG were added to the cells to prevent nonspecific antigen 
binding and solutions of staining antibodies prepared from stocks as follows: 0.2mg/ml CD4 PerCP5.5 
(Biolegend, clone RM4-5) diluted 1/200, 0.5mg/ml CD44 FITC (Biolegend, clone IM7) diluted 1/400, 
0.2mg/ml CD62L PE (Biolegend, clone MEL-14) diluted 1/400, 0.2mg/ml CD8α APC (Biolegend, clone 
53-6.7) diluted 1/400, 0.2mg/ml CDIIb APC (Biolegend, clone M1/7) diluted 1/400 and 0.5mg/ml MHCII 
A700 (Biolegend, clone M5/114.152) diluted 1/400. 50µl of this combined antibody mixture was 
added to the 450µl cell suspension, with single stain controls also carried out to allow correct 
compensation, and the resulting mixtures incubated on ice for 20-30 minutes. 900µl of media was 
then added to each solution to wash off excess antibodies, with the CD4 suspension then centrifuged 
at 405x g for 5 mins (4oC), resuspended in 1ml of complete CD4 media, run through a 70µm cell 
strainer to remove any small clumps and transferred to Flow Assisted Cell Sorting (FACS) tubes. The 
single stains were then run through the cell sorter to determine the correct compensation to be 
applied for background fluorescence, before using this data as parameters to sort live, individual, CD4+ 
naïve cells from both the Wt and KO cell suspensions (i.e. cells which are positive for CD4 and CD62 
and negative for CD44, CD8α, CDIIb and MHCII). 
Samples of these naïve cells were removed and lysed for further analysis and the rest cultured in 96 
well plates, with 3 replicate cultures of 1x106 cells prepared for each treatment. These cultures were 
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stimulated with 10µg/ml platebound anti-CD3 (Biolegend, clone 145-2C11) and 2µg/ml soluble anti-
CD28 (Biolegend, clone 37.51) antibodies with further lineage specific stimulation (Th0 = no further 
stimulation; Th1 = 15ng/ml recombinant IL-12 (Peprotech) and 5µg/ml anti IL-4 (Biolegend, clone 
11B11); Th2 = 5µg/ml anti IFNγ (Biolegend, clone XMG1.2) and 5ng/ml recombinant IL-4 (Peprotech)) 
to induce differentiation of specific CD4+ cell types. These cells were cultured for 4 days, after which 
half the cells were lysed and the remainder were allowed to rest and expand in 10units/ml IL-2 
(Peprotech) to promote further in vitro culture growth and survival, and maintained for a further 2 
days before harvesting (Figure 2).   
 
Figure 2: Simplified diagram of primary CD4+ T cell stimulation and culture 
Mouse tail fibroblast extraction and culture 
Fibroblast cultures were isolated from mouse tails using the protocol detailed by Khan and Gasser 
(2016). Specifically, tails were harvested from 3 Wt and 3 Malat1 KO mice, washed in 70% ethanol and 
air dried for 5 minutes before being placed in dishes containing 10ml of complete fibroblast media 
(1640 RPMI with 10% Fetal Calf Serum (FCS), 100units/ml Penicillin, 100µg/ml Streptomycin, 2mM L-
Glutamine and 100µM L-Asparagine. Each tail was then cut into 2mm segments with sterile scissors 
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and transferred to a cryotube, and a mixture of 2.5mg/ml Collagenase D and 20mg/ml Pronase was 
added to a total volume of 2ml. These tubes were then incubated at 370C for 90 minutes, after which 
the tail segments were placed in a 70µm cell strainer and ground for 5 minutes into a further 10ml of 
media. The cell suspensions were then transferred to Falcon tubes and rinsed twice by centrifuging at 
580x g for 5 minutes (4oC), removing the supernatant and resuspending in 10ml of complete fibroblast 
media. The cells were then transferred to 10cm culture dishes for incubation (37oC, 5% CO2), with the 
media changed every 2 days for the first week and every 3 days afterwards.  
Cultures were passaged upon reaching approximately 70-80% confluence – after removing the media 
and washing with 5ml of PBS (Gibco), each culture was incubated with 2ml of 0.05% Trypsin-EDTA 
solution (ThermoFisher Scientific) for 5 mins (37oC), following which 6ml of complete fibroblast media 
was added for neutralisation and the cells transferred to a 15ml Falcon tube. This was then centrifuged 
for 5 minutes at 450x g, following which the supernatant was removed and the cell pellet resuspended 
in 1ml of complete fibroblast media for cell counts using a haemocytometer, with 10µl of the cell stain 
Trypan Blue (HyClone) added to 10µl samples for easier identification of live and dead cells. The cells 
were then either split evenly between 2 new culture dishes or 2x106 cells used to seed new dishes.  
Fibroblast growth assays 
To set up growth assays from the MTF cultures, the cells were extracted and counted as described 
above, then diluted with complete fibroblast media to 1x105 cells/ml – for assays seeded with smaller 
cell numbers, aliquots of these cell suspensions were taken and diluted 1 in 10 to prepare 1x104 
cells/ml solutions. These diluted culture suspensions were then seeded in triplicate onto 96 well 
plates, with additional complete media added to each well to yield a total volume of 200µl per well 
and blank wells containing only media set up for comparison. These plates were incubated over the 
course of several days – at 24h time points, a plate was taken and 20µl of Alamar Blue (Thermo 
Scientific) added to each well, with further incubation of the plate for 20h to allow greater reduction 
of the resazurin reagent and thus sufficient sensitivity in the final assay. The absorbance of each well 
at 570 and 600 nm was then assessed using a Versamax microplate reader and used to calculate 
optical density, with the average optical densities of each culture and blank control subsequently used 
to determine the adjusted optical density of each culture at the given timepoints.  
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Fibroblast freezing, storage and defrosting 
To freeze and store fibroblast cultures for further culture at a later date, freeze media was initially 
prepared from 90% FCS (HyClone) and 10% DMSO (Sigma) and chilled on ice, and the cells washed and 
lifted from the plates with Trypsin as described above for passage. After centrifuging the cell 
suspensions for 5 minutes at 1200 rpm and removing the resulting supernatant, the cells were 
resuspended in 1ml of chilled freeze media and transferred to a 2ml cryovial. The cryovials were then 
wrapped in layers of paper for insulation and stored at -800C overnight to gradually reduce the sample 
temperature, before transferring the samples to liquid nitrogen storage. In order to defrost these 
frozen samples, the cryovials were taken directly from liquid nitrogen storage and transferred to a 
370C water bath to defrost, following which the cell suspensions were immediately transferred to 6ml 
of complete fibroblast media to dilute the DMSO and thus limit its toxic effects on the cells. After 
centrifuging at 1200 rpm for 5 minutes, the supernatant was then removed and the cells resuspended 
in 6ml of complete fibroblast media before being transferred to a 25ml culture flask (Corning). 
RNA extraction, reverse transcription and qPCR expression analysis 
Cell cultures were extracted by washing each culture once with 1ml PBS and lysing the cells with 700µl 
of Qiazol, with RNA subsequently extracted from these lysates using a miRNeasy Mini Kit (Qiagen, 
catalog no 217004) to produce 30µl of elutant. RNA concentrations and purity were then assessed 
using a Nanodrop spectrophotometer, with higher 260:280 and 260:230 ratios indicating lower levels 
of protein, phenol and carbohydrate contaminants in each 1µl sample. For our experiments, 260:280 
and 260:230 ratios over 2 were considered to represent pure RNA samples, with lower results 
indicating some protein or carbohydrate contamination of the extracted RNA. Additionally, if any RNA 
extraction had a substantially higher or lower concentration than the other samples, appropriate 
dilutions were then prepared from either this sample or the others respectively to ensure 
approximately equal total RNA concentrations across all extractions, generally around 50 – 100 ng/µl.  
Reverse transcription was performed with 1µl of each sample, using 1µl random hexamer primers 
(Invitrogen, 100µM), 1µl dNTPs (ThermoFisher, 10mM), 0.5µl Superscript III (Invitrogen, 200U/µl), 1µl 
RNAse OUT (Invitrogen, 40U/µl), 2µl DTT (Invitrogen, 100mM), and 4µl 5x first-strand buffer 
(Invitrogen; 250 mM Tris-HCl, 375 mM KCl, 15 mM MgCl2), with 9.5µl nuclease free H2O added to give 
a final 20µl cDNA solution. These reagents were used with the First-Strand cDNA synthesis reaction 
specified for SuperScriptTM III Reverse Transcriptase (ThermoFisher, catalog no 18080044). qPCR plates 
were set up from this cDNA, with each well containing 10µl 2X Fast SybrGreen master mix 
(ThermoFisher), 0.6µl each of 10µM primers, 7.8µl nuclease free H2O and 1µl of the cDNA sample, 
with each cDNA sample run in duplicate and averaged to reduce any technical error from the plate 
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readings. For genes tested using Quantitect primer assays (Qiagen), these master mixes were adjusted 
so that each well contained the same volume of Fast SybrGreen master mix and cDNA, but 2µl of the 
10X primer mixture and 7µl of nuclease free H2O instead. These plates were run on a StepOnePlus 
qPCR platform using the protocol specified for Fast SYBR™ Green Master Mix (ThermoFisher, catalog 
no 4385612). The threshold cycle (Ct) at which the fluorescence of each sample rose above a threshold 
level relative to the baseline was recorded, with relative expression levels from each gene and cell 
type determined from the difference in Ct values (ΔCt) between the target gene and a housekeeping 
control as described by Levak and Schmittgen (2001), i.e: 
 ΔCt = Target Ct – Control Ct   Relative expression level = 2ΔCt  
These were then normalised by dividing each result by the relevant control value. 
Statistical testing 
To assess for significant differences between the Wt and Malat1 KO genotypes, relative expression 
levels were normalised to the average Wt results for each cell type and pooled from all experimental 
runs. Unpaired, two-tailed T tests were then used to test for significant differences in gene expression 
between Wt and KO, with Welch’s correction used to compensate for differences in standard 
deviation between the genotypes. To compare expression of genes across different CD4+ cell types, 
the samples were instead normalised to the naïve relative expression levels for each gene, and a one-
way analysis of variance (ANOVA) used to test for significant expression differences between the 
pooled data sets for each CD4+ cell type, with Tukeys multiple comparisons test used to identify 
differences between specific CD4+ cell types. Expression levels of genes in CD4+ and fibroblast cultures 
was compared based upon the non-normalised relative expression values in each cell type, with 
significant differences assessed using a one-way ANOVA and Tukeys multiple comparisons test as for 
expression between CD4+ cell types. 
Primer design, testing and optimisation 
Expression levels of Malat1, Neat1, U6, GAPDH, HPRT, IL-4, IL-10 and IFNγ were assessed using 
previously validated qPCR primer stocks, while qPCR primers for all other genes were designed using 
the online Roche primer design tool and ordered from Sigma. These were reconstituted with nuclease 
free water to 100µM stock solutions, and aliquots of these stocks taken and diluted 1 in 10 to produce 
the final 10µM concentration used in experiments. For some genes whose primer pairs were not 
suitable when generated through this system, due to either primer-dimer interactions or off target 
amplification producing multiple melting curve peaks, Quantitect primer assays (commercially 
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available SYBR Green qPCR primer pairs) were ordered and reconstituted in nuclease free H2O, 
producing a 10X stock solution containing a mixture of forward and reverse primers.  
To test the efficiency and purity of the new primer sets following resuspension, eight existing cDNA 
samples synthesised from liver and spleen tissues of Wt mice were pooled to create a stock cDNA 
solution for expression analysis, with 1 in 4 serial dilutions prepared from this stock solution to 
generate a series of cDNA concentrations ranging from 1 (the undiluted solution) to 1 in 256. qPCRs 
were carried out from these samples using the desired primers, with nuclease free H2O as a negative 
control. The Ct values from each dilution were then plotted against the log10 values for each dilution, 
and the slope of the resulting graph used to assess the amplification efficiency of each primer pair via 
the ThermoFisher qPCR Efficiency calculator located here: 
https://www.thermofisher.com/uk/en/home/brands/thermo-scientific/molecular-
biology/molecular-biology-learning-center/molecular-biology-resource-library/thermo-scientific-
web-tools/qpcr-efficiency-calculator.html 
In addition, the amplification and melt curves were examined to assess the quality of each primer pair, 
with multiple melt curve peaks indicating potential off target amplification or primer-dimer pair 
amplification and closely spaced amplification curve peaks indicating low amplification and possibly 
little to no expression of the gene of interest. 
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Results 
Primer optimisation 
Given that most of our qPCR primer pairs were newly designed for these experiments, each of these 
new primer sets were tested using stock cDNA solutions from liver and spleen samples to assess 
primer efficiency and check for any evidence of off target amplification or primer-dimer interactions. 
Amplification and melting curves of the Malat1 primers were also assessed for the naïve CD4+ samples 
in order to determine if the lncRNA was accurately amplified in these cultures. Based on the liver and 
spleen qPCR data, most of the primer pairs amplified a single product, with the sample melting curves 
forming single, close peaks and indicating little to no primer contamination or primer dimer pair 
formation while the amplification data showed the expected gradient when plotted against the 
different cDNA concentrations, and thus the desired level of amplification efficiency. Though the blank 
samples for several primer pairs, such as Scyl1, Map3k11, Hist1h4a and Las1l, showed some 
amplification of off target products (Figures 4B, 5B, 8B and 12B), this was only observed at high Ct 
values of around 34 – 40, and as such would not affect the comparison of the much lower Ct values 
observed in our CD4+ and fibroblast cultures, typically around 15 – 30. Similarly, while some primer 
sets, such as Scyl1, Hist1h4a, U2af1 and Stau1 show some off-target amplification at around 810C 
(Figures 4B, 8B, 10B and 11B), this was only observed at the highest cDNA concentration, and thus 
likely indicates some slight contamination in the liver/spleen cDNA solution rather than in the primer 
pairs. While some primer sets showed good amplification efficiency, with Hist1h4a, Ddx23 and IFNγ 
primers showing around 80-100% amplification with each PCR cycle, some were less efficient at 
around 75-80% efficiency, including the Scyl1, Map3k11 and U2af1 primer pairs (Table 2). While this 
efficiency is not ideal for expression analysis, it is still within an acceptable level of efficiency for further 
experiments, and as such these primers were used for further CD4+ and fibroblast expression analysis.  
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Primer ID Supplier Sequence Efficiency (%) 
Malat1 forward 
(mouse) 
Eurofins TGCAGTGTGCCAATGTTTCG Not assessed ** 
Malat1 reverse 
(mouse) 
Eurofins GGCCAGCTGCAAACATTCAA Not assessed ** 
Malat1 forward 
(human) 
Eurofins GAATTGCGTCATTTAAAGCCTAGTT Not assessed ** 
Malat1 reverse 
(human) 
Eurofins GTTTCATCCTACCACTCCCAATTAAT Not assessed ** 
Neat1 forward 
(mouse) 
Eurofins CCTAGGTTCCGTGCTTCCTC Not assessed ** 
Neat1 reverse 
(mouse) 
Eurofins CATCCTCCACAGGCTTACCG Not assessed ** 
Neat1 forward 
(human) 
Eurofins ATGGGGAAGTAGTCTCGGGT Not assessed ** 
Neat1 reverse 
(human) 
Eurofins TGAAGGCAATGTGATAGGGGTC Not assessed ** 
Tigd3 forward Qiagen Not available (Qiagen catalog no 
QT00493500) * 
204.92 
Tigd3 reverse Qiagen Not available (Qiagen catalog no  
QT00493500) * 
204.92 
Scyl1 forward Sigma AACCGCTTTGTTGAGACCAA 79.14 
Scyl1 reverse Sigma CTGCTTCTCAGCTGGCTCTT 79.14 
Map3k11 forward Sigma CCCTTTGCACAACTCATGG 78.8 
Map3k11 reverse Sigma CAGGATGGAGGCGAAGTC 78.8 
U6 forward Eurofins TTCACGAATTTGCGTGTCAT Not assessed ** 
U6 reverse Eurofins CGCTTCGGCAGCACATATAC Not assessed ** 
Gapdh forward Sigma GGAGTCAACGGATTTGGTCGTA Not assessed ** 
Gapdh reverse Sigma GGCAACAATATCCACTTTACCAGA Not assessed ** 
Hprt forward Sigma GTTGGATACAGGCCAGACTTTGTTG    Not assessed ** 
Hprt reverse Sigma GATTCAACCTTGCGCTCATCTTAGGC Not assessed ** 
IL-2 forward 
(mouse) 
Sigma GCTGTTGATGGACCTACAGGA Not assessed ** 
IL-2 reverse 
(mouse) 
Sigma TTCAATTCTGTGGCCTGCTT Not assessed ** 
IL-2 forward 
(human) 
Sigma GAATCCCAAACTCACCAGGATGCTC Not assessed ** 
IL-2 reverse 
(human) 
Sigma TAGCACTTCCTCCAGAGGTTTGAGT Not assessed ** 
IFNγ forward Sigma GGATGCATTCATGAGTATTGC 84.37 
IFNγ reverse Sigma GCTTCCTGAGGCTGGATTC 84.37 
IL-4 forward Eurofins CATCGGCATTTTGAACGAG 107.28 
IL-4 reverse Eurofins CGAGCTCACTCTCTGTGGTG 107.28 
IL-10 forward Qiagen Not available (Qiagen catalog 
number QT00106169) * 
Not assessed ** 
IL-10 reverse Qiagen Not available (Qiagen catalog 
number QT00106169) * 
Not assessed ** 
Hist1h4a forward Sigma CCCTGAAAAAGCGCTGTAAT 102.11 
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Table 2: Sources and sequences of all qPCR primer pairs used for expression analysis. N.B: * = sequences of 
Quantitect primer assays were proprietary, and thus unavailable for inclusion. Product numbers have been 
included instead. ** = primers were previously optimised in the Lagos lab from other experiments, and thus 
were not tested. 
  
Hist1h4a reverse Sigma TCCAAAGGCACTCAAGGTTT 102.11 
Ddx23 forward Sigma GAAAGATGGCGACTGTTCG 92.25 
Ddx23 reverse Sigma ATGCGTCTCGGTCCTTTTT 92.25 
U2af1 forward Qiagen Not available (Qiagen catalog 
number QT00175084) * 
79.22 
U2af1 reverse Qiagen Not available (Qiagen catalog 
number QT00175084) * 
79.22 
Stau1 forward Qiagen Not available (Qiagen catalog 
number QT00125069) * 
77.92 
Stau1 reverse Qiagen Not available (Qiagen catalog 
number QT00125069) * 
77.92 
Las1l forward Sigma GCATGGCAAGTAAGCTCTGA 77.33 
Las1l reverse Sigma TTGGTCCAAAAGATACATGGTG 77.33 
Cpsf1 forward Sigma GTCAGGCCTAAAGGGCTATGT 79.38 
Cpsf1 reverse Sigma TCAGGCACCACTTCAATCAC 79.38 
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Figure 3: Tigd3 primer test data, showing (A) amplification curve and (B) melting curve for liver/spleen samples 
Figure 4: Scyl1 primer test data, showing (A) Amplification curve and (B) melting curve for liver/spleen samples 
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Figure 5: Map3k11 primer test data, showing (A) amplification curve and (B) melting curve for liver/spleen 
samples  
Figure 6: IFNγ primer test data, showing (A) amplification curve and (B) melting curve for liver/spleen samples  
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Figure 7: IL-4 primer test data, showing (A) amplification curve and (B) melting curve for liver/spleen samples  
Figure 8: Hist1h4a primer test data, showing (A) amplification curve and (B) melting curve for liver/spleen 
samples 
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Figure 9: Ddx23 primer test data, showing (A) amplification curve and (B) melting curve for liver/spleen samples 
Figure 10: U2af1 primer test data, showing (A) amplification curve and (B) melting curve for liver/spleen samples 
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Figure 11: Stau1 primer test data, showing (A) amplification curve and (B) melting curve for liver/spleen samples 
Figure 12: Las1l primer test data, showing (A) amplification curve and (B) melting curve for liver/spleen samples 
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Figure 13: Cpsf1 primer test data, showing (A) amplification curve and (B) melting curve for liver/spleen samples 
Figure 14: Malat1 primer data, showing (A) amplification curve and (B) melting curve for naïve CD4+ samples 
The Tigd3 primers produced very problematic primer test results, with numerous off target melting 
curve peaks and very little evidence of qPCR amplification observed in the liver/spleen qPCR data 
(Figures 3B and 3A). However, a possible solution may be found in the IL-4 amplification data – while 
the IL-4 amplification curves are similarly closely spaced with considerable off target amplification at 
around 72-730C (Figures 7A and 7B), this likely reflects the extremely low expression of this cytokine 
in liver and spleen cells (Yue et al 2014). Our Tigd3 primers showed similarly close amplification curves 
– furthermore, previous transcriptomic data found very low expression of Tigd3 in human liver, spleen 
and lymph node tissues, and similarly low expression in murine CD4+ cell lines (Fagerberg et al 2014, 
Stubbington et al 2015). This suggests that the results observed for the Tigd3 primers reflect little to 
no expression of the gene in our CD4+ cell cultures, particularly given that three different primer sets, 
including a commercially available Quantitect primer assay, showed similar amplification and melt 
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curve results (data not shown). As such, the Quantitect primer pair was considered viable for further 
expression analysis of Tigd3 – however, given the low expression observed in both T cell and fibroblast 
cultures, significant differences in Tigd3 levels between these cultures should be considered with 
caution. 
Similarly, while the amplification plots for the Malat1 primers showed the expected difference 
between the two genotypes in naive CD4+ cells, with relatively low Ct values for the Wt samples and 
very similar Ct values of around 31-32 for the Malat1 KO samples and blank controls (Figure 14A), the 
melting curve results were unexpected, with strong off target peaks observed from both the Malat1 
KO and blank wells at around 730C (Figure 14B). This amplification likely represents some slight primer 
dimer interactions of the Malat1 primers occurring in the absence of a fully complementary cDNA 
sequence, a possibility supported by both the similarity of the Ct values observed in the blank and 
Malat1 KO samples and the smaller, wider peak observed for these melting curves, as these features 
are consistent with primer-dimer amplifications. However, the KO2 sample, which had a lower Ct value 
than the other KO’s of 29, showed little to no off-target amplification, with the melting curve matching 
those of the Wt samples (Figure 14B) – this indicates that these primer dimer amplifications occur only 
at extremely low levels of Malat1. As such, although these results are not ideal, the Malat1 primers 
appear reliable for assessing the genes expression in CD4+ T cell cultures based on Ct values, provided 
these Ct values are sufficiently lower than that of the negative control.  
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Effects of stimulating immortalised cell lines on Malat1 and Neat1 expression 
 
Figure 15: Relative Malat1 RNA levels in different Wt primary CD4+ cell types, based upon ΔCt between Malat1 
and U6 and normalised to the naïve average. Significance based on one-way ANOVA; * = p<0.05, ** = p<0.01, 
*** = p<0.001, **** = p<0.0001 
Given that previous studies in the Lagos lab showed significant downregulation of Malat1 upon 
activation of primary CD4+ T cells (Hewitson et al unpublished, Figure 15), this project initially aimed 
to determine if immortalised CD4+ cell lines, such as the human and murine cancer cell lines Jurkat 
and EL4, showed similar responses of Malat1 to stimulation and thus might be a viable experimental 
model. These immortalised cell lines are far easier both to culture and maintain over long time periods 
and to manipulate in vitro than harvested primary cells, and thus would be preferable for further 
experiments. To assess this, cultures of Jurkat and EL4 cells were set up and stimulated with ConA or 
a mixture of PMA and PHA respectively, as these mitogens have previously been used in numerous 
studies for stimulation of T cell lines, including Jurkat and EL4 cells (Pang et al 2012, Lim et al 2016). 
These cultures were then incubated for either 24 or 48 hours and harvested, with subsequent RNA 
extraction, reverse transcription and qPCR expression analysis used to compare Malat1 levels 
between stimulated and unstimulated cultures on both days (N.B. For the initial run of Jurkat cultures, 
RNA extraction, reverse transcription and Malat1 and IL-2 qPCR analysis were carried out by Dr 
Dimitris Lagos). EL4 cells were stimulated with different ConA concentrations to determine the ideal 
stimulation treatment for further experiments, using PMA stimulation as a positive control for CD4+ 
stimulation given its effective stimulation of the Jurkat cells, while Neat1 expression was also tested 
to compare the response of another nuclear localised lncRNA potentially regulated by Malat1 
(Nakagawa et al 2012). Relative expression in Jurkat and EL4 cells was based upon ΔCt compared to 
GAPDH and Hprt respectively. 
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Figure 16: PCR expression data from immortalised CD4+ cell cultures. Relative RNA levels of (A) Malat1, (B) Neat1 
and (C) IL-2 in Jurkat cultures are shown (N.B: RNA extraction for one day 1 PMA/PHA culture was unsuccessful 
and thus removed from analysis). Levels of (D) Malat1, (E) Neat1 and (F) IL-2 in EL4 cells, with expression in both 
cell lines normalised to the average of their respective Wt samples. Significance based on 2 tailed t-test; * = 
p<0.05, ** = p<0.01, *** = p<0.001, **** = p<0.0001. 
Jurkat culture Gene 
Malat1 Neat1 IL-2 GAPDH 
d1 unstimulated 16.706 32.80155 31.337014 18.440049 
d1 PMA/PHA 16.09186 32.67733 22.835433 19.191222 
d2 unstimulated 15.12729 32.07893 29.467228 17.010846 
d2 PMA/PHA 15.30054 32.58853 24.417203 19.138806 
Table 3: Average Ct values of Malat1, Neat1 and control genes from qPCR expression analysis of Jurkat cultures. 
Relative expression values for each culture calculated and normalised as detailed in the Methods section. 
EL4 culture Gene 
Malat1 Neat1 IL-2 Hprt 
0.1 20.87462 23.48581 24.796991 24.949281 
1 20.531941 23.600416 26.008762 24.214249 
5 21.340299 26.371088 29.656187 25.413683 
10 20.47501 26.11797 28.009914 25.134259 
PMA control 20.89315 24.661378 22.527192 26.30905 
Untreated 
control 
20.247962 23.341251 29.769643 24.242857 
Table 4: Average Ct values of Malat1, Neat1 and control genes from qPCR expression analysis of EL4 cultures. 
Relative expression values for each culture calculated and normalised as detailed in the Methods section.  
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While in earlier data (Hewitson et al, unpublished) Malat1 was downregulated upon stimulation of 
primary mouse CD4+ T cells, mitogenically stimulated EL4 cultures showed no significant change in 
Malat1 levels. Although an approximately threefold increase was observed with PMA stimulation, the 
low sample size prevented statistical testing of this result (Figure 16D) – however, the highly similar 
Ct values for Malat1 across the EL4 cultures indicates this difference is unlikely to be significant (Table 
4). In Jurkat cells, on the other hand, significantly increased Malat1 expression was observed in 
stimulated cells by the second day of culture – although some increase was observed in the day 1 cells, 
issues with one of the cultures produced too low a sample size for statistical testing (Figure 16A). 
However, the Ct values for Malat1 showed little to no change between these cultures – as such, this 
significant difference in the day 2 cells likely occurred due to slight differences in the GAPDH Ct values 
between stimulated and unstimulated Jurkat cultures (Table 3).  
Similarly, while Neat1 also displayed increased RNA levels in the stimulated Jurkat cultures, reaching 
significance by day 2 similar to Malat1 (Figure 16B), the highly similar Ct values in each culture (Table 
3) suggest this is also due to the altered GAPDH Ct values. Neat1 likewise showed no clear expression 
change upon ConA stimulation of EL4 cells and a notable increase with PHA stimulation of unknown 
significance (Figure 16E) – as with Malat1, this increase might prove significant with larger sample 
sizes, but this is not reflected by the raw Ct values, which seem to indicate a decrease in Neat1 levels 
in this culture (Table 4). Taken together, this data indicates that Malat1 expression patterns and 
function differ between immortalised and primary CD4+ T cell lines, with significant downregulation 
of Malat1 upon T cell receptor activation of primary CD4+ cells (Figure 15) and either slight 
upregulation or no significant change in mitogenically stimulated T cell lines (Figures 16A and 16D). As 
such, these immortalised cell lines would not be a viable in vitro model for assessing regulation by 
Malat1 in primary cells, and primary CD4+ cell cultures were therefore used for all further expression 
analysis of Malat1 and all other genes assessed in these experiments. 
Selection of candidate genes for assessment of Malat1 in cis regulation 
To identify candidate genes for further analysis from those surrounding Malat1, initially the genes 
identified by Zhang et al (2012) to show significant changes in Malat1 knockouts were selected, as 
these had previously shown evidence of potential in cis regulation by Malat1 in a similar KO model. 
Expression levels of these genes across different CD4+ cell types were then compared using the online 
database Th Express, containing data from a previous transcriptomic study of mouse CD4+ T-cells 
(Stubbington et al 2015). This data was assessed for any changes in expression corresponding to 
changes in Malat1 levels, as such similarities might indicate regulation of the target gene by Malat1. 
Previous data on Malat1 function and interactions was also considered, as well as the relative location 
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of each gene to the Malat1 locus, to determine a final pool of candidate genes for CD4+ expression 
analysis. 
 
Figure 17: Relative CD4+ expression levels of neighbouring genes of Malat1, based on previous transcriptomic 
data (Stubbington et al 2015). Expression levels of (A) Malat1, (B) Neat1, (C) Tigd3, (D) Scyl1, (E) Map3k11, (F) 
Frmd8, (G) Ehbp1l1, (H) Ltbp3, (I) Kcnk7, (J) Slc25a45, (K) Dpf2 and (L) Cdc42ep2 are plotted as length normalised 
counts for each CD4+ subtype, including naïve, Th1, Th2 and Th17 lines, regulatory T cells (Treg) and induced 
regulatory T cells (iTreg). Expression was based on RNA sequencing counts, normalised by transcript length to 
allow more accurate comparison of mRNA levels between genes sequenced to different depths.  
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While most of the genes surrounding Malat1 showed no clear pattern of CD4+ expression, with very 
different patterns of up- and down-regulation across different cell types, several potential candidate 
genes were identified based on this transcriptomic database. Initially, Nuclear Enriched Abundant 
Transcript 1 (Neat1), another nuclear localised lncRNA with key functions in alternative splicing 
structures known as paraspeckles (Clemson et al 2009, Lin et al 2018), was assessed given both the 
similar patterns of downregulation to Malat1 observed in stimulated CD4+ cultures (Figure 17B) and 
the fact that two separate Malat1 knockout papers found evidence of Neat1 regulation by Malat1 
(Zhang et al 2012, Nakagawa et al 2012). Furthermore, other studies have shown matching functional 
roles for Malat1 and Neat1, with the two lncRNAs targeting and binding jointly to numerous active 
genomic sites (West et al 2014). Additionally, both genes showed very similar patterns of expression 
across CD4+ cell types (Stubbington et al 2015). Tigger Transposable Derived Element 3 (Tigd3), a 
nuclear localised paralogue of centromere binding proteins (Marshall and Choo 2012), also showed 
similar expression changes to both Malat1 and Neat1 across the CD4+ transcriptomic data (Figure 17C) 
– this suggests that Tigd3 may be regulated by or functionally linked to Malat1 in mouse CD4+ cells, 
and as such the gene was likewise selected for further analysis.  
Scy Like 1 (Scyl1), a catalytically inactive pseudokinase with key regulatory functions in Golgi body 
homeostasis and neuronal survival (Burman et al 2010, Schmidt et al 2007), was also selected for 
further analysis. This choice was primarily based on the genes location immediately downstream of 
Malat1 (Figure 1B) – given that numerous examples of in cis regulation by other lncRNAs have been 
found to regulate downstream or nearby gene expression by various mechanisms, such as 
transcriptional interference (Ard et al 2014, Ard et al 2016), Scyl1 would be one of the most likely 
candidates for in cis regulation by Malat1. Finally, Mitogen Activated Protein Kinase Kinase Kinase 11 
(Map3k11), a serine threonine kinase which functions as a positive regulator of JNK signalling and as 
a tumour suppressor in prostate cancers and B-lymphocytes (Gallo and Johnson 2002, Whitworth et 
al 2012, Knackmuss et al 2016), was found to show similar CD4+ expression patterns to Scyl1 (Figures 
17D and 17E). This suggested potential coregulation of Scyl1 and Map3k11 by a common factor which 
might be Malat1 – furthermore, as Map3k11 was the only one of these four genes transcribed from 
the opposite strand to Malat1, it allowed potential in cis regulation of this strand by Malat1 to be 
assessed. 
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Effects of Malat1 knockout on surrounding gene expression in CD4+ T cells 
To assess potential in cis regulation by Malat1 of its surrounding genes, phenotypically naïve primary 
CD4+ T cells (CD4+ CD62L+ CD44-) were sorted from naïve Wt and Malat1 KO mice and differentiated 
in vitro to generate Th0, Th1 and Th2 primary cells. RNA was then isolated from three cultures of each 
cell type at 4 or 6 days of culture, and qPCR expression analysis used to assess expression levels of 
several candidate genes surrounding Malat1. The ubiquitous snRNA U6 was used as a housekeeping 
control to determine relative expression, as HPRT and GAPDH expression were shown to differ 
between CD4+ cell types in a previous CD4+ transcriptomic study (Stubbington et al 2015), whereas 
our qPCR data showed very similar Ct values for U6 across all CD4+ subtypes. Normalised relative 
expression levels of each gene were then tested to identify any significant expression differences 
between the Wt and Malat1 KO cultures. Expression levels were also compared between CD4+ cell 
types to determine if any expression changes observed between cell types were consistent with 
existing transcriptomic data on mouse CD4+ cells. The raw Ct values were used to screen for very low 
expression levels of any genes in the cultures, indicated by similar Ct values to the negative control, 
as any significant differences observed between such low levels should be treated with caution. 
Expression levels of IFNγ, IL-4 and IL-10 were tested as controls for CD4+ polarisation, with IFNγ used 
as a positive control of Th1 activation and IL-4 and IL-10 as positive controls of Th2 activation (N.B. for 
IFNγ, day 4 IL-10 data and the day 6 IL-4 data, the qPCRs were performed by Laura Chaffey). 
Gene IFNγ IL-4 IL-10 U6 
Wt KO Wt KO Wt KO Wt KO 
Naïve 35.59 33.83 34.91 34.76 35.60 38.11 21.92 21.87 
d4 Th0 31.48 30.71 30.70 32.29 36.05 36.05 21.72 21.59 
d4 Th1 24.54 24.27 33.90 33.37 33.96 33.23 21.80 22.31 
d4 Th2 33.14 32.42 27.28 26.66 28.59 29.64 21.86 21.66 
d6 Th0 32.89 31.43 30.50 31.52 35.46 35.75 20.87 20.84 
d6 Th1 23.18 26.42 31.50 34.48 33.18 36.23 20.84 21.35 
d6 Th2 35.30 33.50 24.07 22.69 26.49 26.54 21.53 21.50 
Fibroblasts N/A * N/A * N/A * N/A * N/A * N/A * 20.64 20.70 
Negative 
control 
Not tested ** 34.60 38.66 35.76 
Table 5: Average Ct values of CD4+ and relative expression control genes from qPCR expression analysis across 
CD4+ and fibroblast cell types. Relative expression values for each culture calculated and normalised as detailed 
in the Methods section. N.B: * = cytokine controls were used to assess CD4+ polarisation in response to 
stimulation, and thus were not tested in fibroblasts. ** = No negative control data could be found for the IFNγ 
qPCRs – as such, the high Ct values for the naïve cells and some stimulated CD4+ cultures were taken to indicate 
minimal expression. However, as significant differences were only observed between these cultures and much 
lower Ct values, this was not deemed to affect expression analysis.  
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Figure 18: IFNγ qPCR expression data from CD4+ cell cultures, showing relative RNA levels based upon differences 
in Ct values (ΔCt) between IFNγ and U6. (A) Relative IFNγ levels in Wt and KO cultures, normalised to the average 
of the Wt samples for each cell type. Significance based on 2 tailed t-test. (B) Relative IFNγ levels in different 
CD4+ cell types, normalised to the Wt Th1 average for each culture time. Significance based on one-way ANOVA; 
* = p<0.05, ** = p<0.01, *** = p<0.001, **** = p<0.0001 
Expression of cytokines associated with Th1 and Th2 differentiation differed as expected between the 
CD4+ cell types – while significance could not be tested between the stimulated cultures and the single 
naïve cell sample, IFNγ expression was significantly increased specifically in Th1 cells compared to Th0 
and Th2 for both the Wt cultures and the day 6 Malat1 KO culture (Figure 18B). Similarly, Th2 cells 
showed significantly greater IL-4 levels than Th0 or Th1 cells across all cultures (Figure 19B) and 
significantly greater IL-10 levels in all Malat1 KO cultures and the day 4 Wt cultures (Figure 20B). Both 
IFNγ and IL-4 showed some significant expression changes between the Wt and Malat1 KO cells, with 
IFNγ expression significantly increased in the day 6 Th0 knockouts and IL-4 expression significantly 
decreased in the day 4 Th0 knockouts (Figures 18A and 19A). However, given that the Ct values of 
each cytokine in these cultures indicate very low expression in both genotypes (Table 5), the functional 
importance of such results is debatable. Overall, this indicates that stimulation of the different CD4+ 
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cell types was successful, with significant upregulation of CD4+ cell type specific cytokines in the 
expected cell types. 
 
Figure 19: IL-4 qPCR expression data from CD4+ cell cultures, showing relative RNA levels based upon differences 
in Ct values (ΔCt) between IL-4 and U6. (A) Relative IL-4 levels in Wt and KO cultures, normalised to the average 
of the Wt samples for each cell type. Significance based on 2 tailed t-test. (B) Relative IL-4 levels in different CD4+ 
cell types, normalised to the Wt Th2 average for each culture time. Significance based on one-way ANOVA; * = 
p<0.05, ** = p<0.01, *** = p<0.001, **** = p<0.0001 
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Figure 20: IL-10 qPCR expression data from CD4+ cell cultures, showing relative RNA levels based upon 
differences in Ct values (ΔCt) between IL-10 and U6. (A) Relative IL-10 levels in Wt and KO cultures, normalised 
to the average of the Wt samples for each cell type. Significance based on 2 tailed t-test. (B) Relative IL-10 levels 
in different CD4+ cell types, normalised to the Wt Th2 average for each culture time. Significance based on one-
way ANOVA; * = p<0.05, ** = p<0.01, *** = p<0.001, **** = p<0.0001 
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Figure 21: Malat1 qPCR expression data from CD4+ cell cultures, showing relative RNA levels based upon 
differences in Ct values (ΔCt) between Malat1 and U6. (A) Relative Malat1 levels in Wt and KO cultures, 
normalised to the average of the Wt samples for each cell type. Significance based on 2 tailed t-test. (B) Relative 
Malat1 levels in different CD4+ cell types, normalised to the naïve average for each genotype and culture time. 
Significance based on one-way ANOVA; * = p<0.05, ** = p<0.01, *** = p<0.001, **** = p<0.0001 
In our CD4+ cultures, Malat1 levels were significantly reduced in the Malat1 KO cells compared to Wt 
for both the naïve CD4+ cells and most of the stimulated cultures after both 4 and 6 days of culture 
(Figure 21A). This was in agreement with unpublished data from the Lagos group (Hewitson et al, 
unpublished). Furthermore, the stimulated Wt cultures all showed significantly reduced expression 
compared to the Wt naïve results (Figure 21B), which is consistent with Malat1 CD4+ expression data 
both from previous experiments in this lab and from prior transcriptomic studies (Hewitson, 
unpublished, Stubbington et al 2015). However, while the naïve Malat1 KO cells showed little to no 
Malat1 expression as expected (Table 6), all the stimulated KO cultures showed some level of residual 
Malat1 expression (Figure 21B), to the extent that the day 4 Th2 Wt and KO samples did not 
significantly differ (Figure 21A, p = 0.065) due to a combination of the increased Malat1 levels in the 
KO cells, reduced Malat1 expression in Wt cells and the low sample number for this experiment. As 
such, our data indicates that CD4+ stimulation produces residual Malat1 expression in the knockout 
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CD4+ cultures, though this may reflect increased formation of Malat1 primer dimers at these relatively 
low levels of expression. 
Figure 22: Neat1 qPCR expression data from CD4+ cell cultures, showing relative RNA levels based upon 
differences in Ct values (ΔCt) between Neat1 and U6. (A) Relative Neat1 levels in Wt and KO cultures, normalised 
to the average of the Wt samples for each cell type. Significance based on 2 tailed t-test. (B) Relative Neat1 levels 
in different CD4+ cell types, normalised to the naïve average for each genotype and culture time. Significance 
based on one-way ANOVA; * = p<0.05, ** = p<0.01, *** = p<0.001, **** = p<0.0001 
Similar to Malat1, Neat1 expression was significantly reduced in the stimulated CD4+ cultures 
compared to the naïve cells, though this reduction in stimulated CD4+ expression was consistent for 
both the Wt and Malat1 KO cultures (Figure 22B). Furthermore, the KO cells showed significantly 
reduced Neat1 expression compared to Wt in the naïve, day 4 Th0 and day 6 Th1 cultures (Figure 22A), 
indicating some potential regulation by Malat1 under cell type specific conditions.  
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Figure 23: Tigd3 qPCR expression data from CD4+ cell cultures, showing relative RNA levels based upon 
differences in Ct values (ΔCt) between Tigd3 and U6. (A) Relative Tigd3 levels in Wt and KO cultures, normalised 
to the average of the Wt samples for each cell type. Significance based on 2 tailed t-test. (B) Relative Tigd3 levels 
in different CD4+ cell types, normalised to the naïve average for each genotype and culture time. Significance 
based on one-way ANOVA; * = p<0.05, ** = p<0.01, *** = p<0.001, **** = p<0.0001 
Tigd3 levels showed some differences between naïve and stimulated Wt CD4+ T cells, with significantly 
increased expression in all the day 4 stimulated Wt cultures and in the day 6 Th2 Wt culture compared 
to both naïve cells and the other CD4+ cell types (Figure 23B). However, the Malat1 KO cells showed 
very different expression patterns across the CD4+ cell types, with no significant differences between 
any of the day 4 cultures and significantly increased expression in the day 6 Th2 cultures compared to 
the naïve and Th0 CD4+ cells (Figure 23B). As previously detailed, the very low levels of Tigd3 in these 
CD4+ cultures, as indicated by their Ct values (Table 6), makes it challenging to judge the relevance of 
any such differences in expression. Furthermore, none of these CD4+ cultures showed a significant 
difference in Tigd3 levels between the Wt and Malat1 KO cells (Figure 23A), indicating an apparent 
lack of regulation of the gene by Malat1 in CD4+ T cells. 
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Figure 24: Scyl1 qPCR expression data from CD4+ cell cultures, showing relative RNA levels based upon 
differences in Ct values (ΔCt) between Scyl1 and U6. (A) Relative Scyl1 levels in Wt and KO cultures, normalised 
to the average of the Wt samples for each cell type. Significance based on 2 tailed t-test. (B) Relative Scyl1 levels 
in different CD4+ cell types, normalised to the naïve average for each genotype and culture time. Significance 
based on one-way ANOVA; * = p<0.05, ** = p<0.01, *** = p<0.001, **** = p<0.0001 
Although Scyl1 levels were significantly reduced in the day 4 stimulated CD4+ cultures, with the Ct 
values indicating negligible expression of the gene at this timepoint (Table 6), this significant 
difference was not observed in the day 6 cultures (Figure 24B). While the initial run of CD4+ cultures 
showed substantially reduced Scyl1 expression in the stimulated cultures at day 6, the second sample 
set showed far less change in Scyl1 levels between the stimulated and naïve cells (Figure 24B), 
indicating some variability in the responses of the two CD4+ culture sets to stimulation. Interestingly, 
Scyl1 levels were both significantly increased in the naïve and d4 Th0 Malat1 KOs and significantly 
decreased in the d6 Th0 Malat1 KOs (Figure 24A). Although the negligible day 4 Th0 expression of 
Scyl1 makes the relevance of the associated significant change difficult to assess (Table 6), these 
differing significant expression changes in the naïve and day 6 Th1 cultures both indicate that Malat1 
has some role in regulating Scyl1 in CD4+ T cells and further highlighting the apparent cell type 
specificity of such regulation. 
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Figure 25: Map3k11 qPCR expression data from CD4+ cell cultures, showing relative RNA levels based upon 
differences in Ct values (ΔCt) between Map3k11 and U6. (A) Relative Map3k11 levels in Wt and KO cultures, 
normalised to the average of the Wt samples for each cell type. Significance based on 2 tailed t-test. (B) Relative 
Map3k11 levels in different CD4+ cell types, normalised to the naïve average for each genotype and culture time. 
Significance based on one-way ANOVA; * = p<0.05, ** = p<0.01, *** = p<0.001, **** = p<0.0001 
Map3k11 showed similar expression changes to Scyl1 across the Wt CD4+ cell types, with significantly 
reduced levels in the stimulated day 4 cultures compared to naïve cells and no significant expression 
changes in the day 6 cultures (Figure 25B). The Malat1 KO cultures showed similar results, although 
here the day 6 Th2 KO cells showed significantly decreased Map3k11 levels compared to the naïve 
cells (Figure 25B). Furthermore, the two day 6 sample sets showed a similar difference in Map3k11 
expression to Scyl1, with the initial CD4+ cultures showing substantially reduced expression and the 
second set of cultures showing little to no change in expression (Figure 25A). Only one CD4+ cell type 
showed significantly altered Map3k11 levels in the Malat1 KO cultures, with significantly decreased 
expression in the day 6 Th1 cells. Altogether, this CD4+ expression data suggests that Malat1 does 
appear to regulate some of its surrounding genes, but this regulation is highly specific to certain cell 
types and conditions. 
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Effects of Malat1 knockout on surrounding gene expression in fibroblasts 
To determine if these effects were specific to CD4+ T cell lineages, mouse tail fibroblast (MTF) cultures 
were established from tail samples of Wt and Malat1 KO mice and harvested after 3 passages, with 
subsequent RNA extraction, reverse transcription and qPCR analysis carried out to compare 
expression of these genes in Wt and Malat1 KO cultures. Malat1 expression was, as expected, 
significantly lower in Malat1 KO cultures than in Wt (Figure 26A), though of the genes surrounding 
Malat1 only Scyl1 showed a significant difference in RNA levels, with significantly greater expression 
in Malat1 KO cultures than in Wt (Figure 26D). Therefore, regulation of these genes by Malat1 differs 
between immune and non-immune cells, further indicating that such regulation is apparently cell type 
specific.  
Figure 26: qPCR expression data from MTF cell cultures, showing relative RNA levels of (A) Malat1, (B) Neat1, 
(C) Tigd3, (D) Scyl1 and (E) Map3k11 based upon differences in Ct values (ΔCt) between the gene and U6 and 
normalised to the average of the Wt samples. Significance based on 2 tailed t-test; * = p<0.05, ** = p<0.01, *** 
= p<0.001, **** = p<0.0001 
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Relative expression values for each gene were also compared between the CD4+ and MTF cultures to 
compare expression levels of these genes in both cell types and determine if any differences observed 
corresponded to the variations in Malat1 regulation observed. Relative expression levels of both 
Malat1 and Neat1 were significantly greater in fibroblasts compared to all CD4+ cultures, with similarly 
significant increases across both Wt and Malat1 KO cells (Figures 27 and 28). While Scyl1 also showed 
significantly increased fibroblast expression compared to both Wt and Malat1 KO Th cell cultures, the 
degree of significance varied considerably between different Wt cultures (Figures 30A and 30B). 
Although Tigd3 showed numerous expression changes between the fibroblast and CD4+ cell types, 
such as significantly reduced levels in fibroblasts compared to day 4 Th0 and Th1 cells of both 
genotypes (Figures 29A and 29B), the importance of these results should be considered carefully given 
the very low relative expression of Tigd3 observed across all cell types (Table 4) and the off-target 
amplification observed in the primer test data (Figure 3B). Finally, relative RNA levels of Map3k11 in 
fibroblasts were significantly lower than naïve CD4+ cells in the Wt cultures (Figure 31A) and 
significantly greater than the day 4 stimulated cultures of Malat1 KO cells (Figure 31B). Overall, while 
Malat1 and these surrounding genes all show some significant differences in expression levels 
between the CD4+ and fibroblast cultures, these changes do not correspond to the differing evidence 
of Malat1 regulation between the two cell types, indicating that these distinct patterns of surrounding 
gene regulation by Malat1 arise from cell type specificity rather than differing gene expression. 
Gene Malat1 Neat1 Tigd3 Scyl1 Map3k11 U6 
Wt KO Wt KO Wt KO Wt KO Wt KO Wt KO 
Naïve 18.34 31.39 23.37 24.54 31.83 31.52 26.16 25.86 26.41 26.36 21.92 21.87 
d4 Th0 24.79 29.79 28.99 29.32 31.43 30.97 34.73 32.87 29.30 29.60 21.72 21.59 
d4 Th1 24.91 30.89 29.04 29.22 31.66 31.68 34.60 33.98 29.72 30.35 21.80 22.31 
d4 Th2 24.61 30.01 28.47 28.62 31.20 31.60 33.71 33.06 30.05 29.60 21.86 21.66 
d6 Th0 21.08 28.43 26.58 27.12 31.07 31.06 26.15 25.91 26.73 26.67 20.87 20.84 
d6 Th1 21.16 28.29 26.93 27.82 31.22 31.19 26.13 28.16 26.55 28.31 20.84 21.35 
d6 Th2 20.89 27.95 26.43 27.15 31.18 30.79 27.79 27.48 28.05 28.29 21.53 21.50 
Fibroblasts 16.12 24.45 20.14 20.19 30.76 30.60 23.60 22.91 26.42 25.85 20.64 20.70 
Negative 
control 
34.88 33.29 32.24 34.50 36.59 35.76 
Table 6: Average Ct values of Malat1 and surrounding genes from qPCR expression analysis across CD4+ and 
fibroblast cell types, along with the U6 control. Relative expression values for each culture calculated and 
normalised as detailed in the Methods section. 
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Figure 27: Comparison of relative Malat1 RNA levels in CD4+ cell types and fibroblasts from (A) Wt and (B) Malat1 
KO cultures, based on ΔCt between the gene and U6. Significance based on one-way ANOVA; * = p<0.05, ** = 
p<0.01, *** = p<0.001, **** = p<0.0001 
 
 
 
Figure 28: Comparison of relative Neat1 RNA levels in CD4+ cell types and fibroblasts from (A) Wt and (B) Malat1 
KO cultures, based on ΔCt between the gene and U6. Significance based on one-way ANOVA; * = p<0.05, ** = 
p<0.01, *** = p<0.001, **** = p<0.0001 
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Figure 29: Comparison of relative Tigd3 RNA levels in CD4+ cell types and fibroblasts from (A) Wt and (B) Malat1 
KO cultures, based on ΔCt between the gene and U6. Significance based on one-way ANOVA; * = p<0.05, ** = 
p<0.01, *** = p<0.001, **** = p<0.0001 
 
 
Figure 30: Comparison of relative Scyl1 RNA levels in CD4+ cell types and fibroblasts from (A) Wt and (B) Malat1 
KO cultures, based on ΔCt between the gene and U6. Significance based on one-way ANOVA; * = p<0.05, ** = 
p<0.01, *** = p<0.001, **** = p<0.0001 
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Figure 31: Comparison of relative Map3k11 RNA levels in CD4+ cell types and fibroblasts from (A) Wt and (B) 
Malat1 KO cultures, based on ΔCt between the gene and U6. Significance based on one-way ANOVA; * = p<0.05, 
** = p<0.01, *** = p<0.001, **** = p<0.0001  
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Effects of Malat1 knockout on interacting RNA binding proteins 
Given this apparent cell type specific regulation of the genes surrounding Malat1, the CD4+ cultures 
were then used to assess if other genes interacting with Malat1 showed evidence of similar regulation 
in trans. To this end, 6 genes were identified with products previously shown to interact with Malat1 
at either the protein or mRNA stage (Chen et al 2017, Engreitz et al 2014) and with various functions 
in RNA binding, processing and degradation. Specifically, the majority of these candidate genes have 
known functions in regulation and processing of the pre-mRNA spliceosome, a cellular process with 
which Malat1 has been found to be very strongly associated (Chen et al 2017, Engreitz et al 2014) and 
thus is likely to have some role in regulating. Based upon this association, the genes selected for 
analysis were the histone subunit protein Hist1h4a (Marzluff et al 2002), the pre-miRNA processing 
DEAD-box helicase Ddx23 (Chu et al 2016), the pre-mRNA splicing complex component U2af1 (Okeyo-
Owuor et al 2015), the double stranded RNA binding and mRNA decay protein Stau1 (LeGendre et al 
2013), the ribosomal RNA processing and biogenesis protein Las1l (Castle et al 2010) and the 
alternative splicing specificity complex subunit Cpsf1 (Evsyukova et al 2012). While these genes were 
not the most strongly associated with Malat1 in this previous interactome data (Engreitz et al 2014), 
they were all found to show similar patterns of expression to Malat1 across CD4+ cell types, with 
strong downregulation in stimulated cultures from earlier transcriptomic data (Stubbington et al 
2015). Together with the Malat1 interactome data, these genes show further evidence of possible 
regulation by Malat1 in trans – as such, expression levels of these genes in the CD4+ cultures were 
therefore assessed by further qPCR expression analysis and compared between both the Wt and 
Malat1 genotypes and the different CD4+ cell types as with the surrounding genes. However, as only 
a single Naïve sample was available for the CD4+ sample set tested here, significant expression 
differences between the naïve and stimulated cultures could not be fully assessed. 
Gene Hist1h4a Ddx23 U2af1 Stau1 Las1l Cpsf1 U6 
Wt KO Wt KO Wt KO Wt KO Wt KO Wt KO Wt KO 
Naïve 34.18 36.52 34.39 38.61 32.53 31.78 31.88 31.68 33.40 34.09 34.70 35.66 21.93 21.60 
d4 Th0 27.38 27.24 37.11 35.01 25.67 25.26 32.02 31.96 32.57 30.61 35.56 35.51 21.72 21.59 
d4 Th1 27.03 28.09 34.66 36.02 25.73 26.35 31.60 32.02 31.54 31.42 35.13 34.97 21.80 22.31 
d4 Th2 27.60 28.09 36.22 33.73 26.26 25.71 31.79 31.72 31.44 29.87 34.91 34.43 21.86 21.66 
d6 Th0 28.47 29.09 27.21 26.29 25.64 26.19 31.40 31.30 35.41 34.31 38.67 38.45 20.75 20.73 
d6 Th1 29.97 29.49 26.45 31.11 26.02 27.29 31.22 31.10 33.85 33.67 36.63 39.12 21.25 22.11 
d6 Th2 31.47 31.30 32.79 29.28 26.65 26.08 31.22 31.10 33.74 34.01 37.35 39.72 22.33 22.15 
Negative 
control 
38.25 37.94 38.53 31.58 35.14 35.01 33.87 
Table 7: Average Ct values of Malat1 interacting, RNA binding genes from qPCR expression analysis across CD4+ 
cell types, along with the U6 control. Relative expression values for each culture calculated and normalised as 
detailed in the Methods section.  
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Figure 32: Hist1h4a qPCR expression data from CD4+ cell cultures, showing relative RNA levels based upon 
differences in Ct values (ΔCt) between Hist1h4a and U6. (A) Relative Hist1h4a levels in Wt and KO cultures, 
normalised to the average of the Wt samples for each cell type. Significance based on 2 tailed t-test. (B) Relative 
Hist1h4a levels in different CD4+ cell types, normalised to the naïve average for each genotype and culture time. 
Significance based on one-way ANOVA; * = p<0.05, ** = p<0.01, *** = p<0.001, **** = p<0.0001 
Both the day 4 and day 6 stimulated Wt CD4+ cultures showed substantial increases in Hist1h4a levels 
compared to the minimal expression observed in Naïve cells (Table 7) – however, this increase was far 
less in the day 6 cultures than the day 4 cultures, with significantly lower Hist1h4a expression in the 
Th2 cells than in Th0 at this timepoint (Figure 32B). More ample increases in expression were observed 
in the stimulated Malat1 KO cultures at both time points, although these showed similar patterns of 
less substantial increases on day 6 of culture than on day 4 (Figure 32B). While some differences in 
Hist1h4a expression levels were observed between the Wt and Malat1 KO cultures, these differences 
were not significant in any of the CD4+ cell types (Figure 32A). 
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Figure 33: Ddx23 qPCR expression data from CD4+ cell cultures, showing relative RNA levels based upon 
differences in Ct values (ΔCt) between Ddx23 and U6. (A) Relative Ddx23 levels in Wt and KO cultures, normalised 
to the average of the Wt samples for each cell type. Significance based on 2 tailed t-test. (B) Relative Ddx23 
levels in different CD4+ cell types, normalised to the naïve average for each genotype and culture time. 
Significance based on one-way ANOVA; * = p<0.05, ** = p<0.01, *** = p<0.001, **** = p<0.0001 
While the Wt stimulated CD4+ cell cultures showed some slight reduction in Ddx23 expression at day 
4, with the Ct values indicating very low Ddx23 levels in both the naïve and day 4 cultures (Table 7), 
this expression is substantially increased by day 6, with significantly higher expression levels in the Th1 
cells compared to Th2 (Figure 33B). The Malat1 KO CD4+ cultures showing increased expression 
compared to naïve cells at both timepoints, with significantly greater Ddx23 expression in the d6 Th0 
culture compared to both Th1 and Th2 cells (Figure 33B). Furthermore, while Ddx23 expression levels 
did differ somewhat between the Wt and Malat1 KO cells across the CD4+ cultures, none of these 
differences were significant (Figure 33A). 
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Figure 34: U2af1 qPCR expression data from CD4+ cell cultures, showing relative RNA levels based upon 
differences in Ct values (ΔCt) between U2af1 and U6. (A) Relative U2af1 levels in Wt and KO cultures, normalised 
to the average of the Wt samples for each cell type. Significance based on 2 tailed t-test. (B) Relative U2af1 levels 
in different CD4+ cell types, normalised to the naïve average for each genotype and culture time. Significance 
based on one-way ANOVA; * = p<0.05, ** = p<0.01, *** = p<0.001, **** = p<0.0001 
The day 4 Wt CD4+ cultures showed a slight reduction in U2af1 levels compared to naïve cells, with 
little to no reduction observed in the day 6 Wt cultures and more substantial decreases in expression 
in the Malat1 KO cultures at both time points (Figure 34B). However, U2af1 expression across the 
stimulated CD4+ cell types did not significantly differ in any of our cultures (Figure 34B). Notably, U2af1 
levels were significantly altered only in a single set of Malat1 KO cultures, with increased expression 
in the day 6 Th2 culture compared to Wt cells (Figure 34A). This indicates some in trans regulation of 
the gene by Malat1, with similar cell type specificity to that observed in the genes surrounding Malat1. 
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Figure 35: Stau1 qPCR expression data from CD4+ cell cultures, showing relative RNA levels based upon 
differences in Ct values (ΔCt) between Stau1 and U6. (A) Relative Stau1 levels in Wt and KO cultures, normalised 
to the average of the Wt samples for each cell type. Significance based on 2 tailed t-test. (B) Relative Stau1 levels 
in different CD4+ cell types, normalised to the naïve average for each genotype and culture time. Significance 
based on one-way ANOVA; * = p<0.05, ** = p<0.01, *** = p<0.001, **** = p<0.0001 
Both the day 4 and day 6 Wt CD4+ cultures showed little to no difference in Stau1 expression across 
the stimulated and naïve cells, save for a significant increase in the d6 Th2 culture compared to the 
Th0 and Th1 cells (Figure 35B). Malat1 KO cultures showed similarly little change in Stau1 levels at day 
4, with a slight increase in the day 6 Th1 and Th2 culture (Figure 35B) – however, the Ct values for 
each culture indicated little to no expression of Stau1 across all CD4+ cell types (Table 7), and as such 
the relevance of such differences is difficult to judge. Similarly, Stau1 levels did not significantly differ 
between Wt and Malat1 KO cultures across any of the CD4+ cell types (Figure 35A). 
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Figure 36: Las1l qPCR expression data from CD4+ cell cultures, showing relative RNA levels based upon 
differences in Ct values (ΔCt) between Las1l and U6. (A) Relative Las1l levels in Wt and KO cultures, normalised 
to the average of the Wt samples for each cell type. Significance based on 2 tailed t-test. (B) Relative Las1l levels 
in different CD4+ cell types, normalised to the naïve average for each genotype and culture time. Significance 
based on one-way ANOVA; * = p<0.05, ** = p<0.01, *** = p<0.001, **** = p<0.0001 
While Las1l levels were increased in the stimulated day 4 Wt cultures compared to naïve cells (Figure 
36B), the day 6 Wt cultures showed little change from the naïve, with the Ct values indicating negligible 
expression in these cell types (Table 7). Similarly, the KO cultures displayed considerably increased 
Las1l levels at day 4, but little to no change in Las1l expression at day 6 (Figure 36B). In spite of this, 
no significant difference in Las1l expression was observed between the stimulated CD4+ cell types 
across either genotype. Interestingly, Las1l showed some response to Malat1 in specific CD4+ cell 
types, being significantly upregulated in the day 4 Th0 knockout cultures specifically (Figure 36A). As 
with U2af1, this suggests cell type specific in trans regulation of the gene by Malat1. 
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Figure 37: Cpsf1 qPCR expression data from CD4+ cell cultures, showing relative RNA levels based upon 
differences in Ct values (ΔCt) between Cpsf1 and U6. (A) Relative Cpsf1 levels in Wt and KO cultures, normalised 
to the average of the Wt samples for each cell type. Significance based on 2 tailed t-test. (B) Relative Cpsf1 levels 
in different CD4+ cell types, normalised to the naïve average for each genotype and culture time. Significance 
based on one-way ANOVA; * = p<0.05, ** = p<0.01, *** = p<0.001, **** = p<0.0001 
Both the Wt and Malat1 KO stimulated CD4+ cultures showed substantially reduced expression of 
Cpsf1 compared to naïve cells at day 4, with far less of a decrease in Cpsf1 levels observed in the Wt 
cultures at day 6 and little to no change in the day 6 Th2 cultures (Figure 37B). However, Cpsf1 
expression did not significantly differ between the simulated Th cell types in any culture, despite the 
varying expression observed in the day 6 Wt culture (Figure 37B), with the Ct values across the cultures 
indicating negligible expression of Cpsf1 in all CD4+ cell types (Table 5). Similarly, none of these cell 
types showed significant differences in Cpsf1 expression between the Wt and Malat1 KO genotypes 
at either timepoint (Figure 37A).  
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Fibroblast culture analysis 
As previous studies of Malat1 have shown knockdown of the gene to significantly impair growth and 
proliferation of various cell types, including fibroblasts (Tripathi et al 2013), the effects of Malat1 KO 
on growth of our MTF cultures were then tested for comparison. To this end, culture growth assays 
were set up from the MTF cultures at either 3 or 4 passages and run for up to 96h, with proliferation 
of each culture assessed by comparing the adjusted optical densities between the Wt and Malat1 KO 
genotypes, between different initial cell densities and between different time points for each MTF 
culture. The plates were each visually examined on each day as well to assess any changes in 
confluence and the general health of the culture. The initial growth assay was seeded with either 500 
or 1000 cells/well, while the subsequent final assay was set up with 5000, 10000 or 15000 cells in each 
well. 
Figure 38: Fibroblast growth data, showing average optical density of plates seeded with (A) 5000, (B) 10000 or 
(C) 15000 cells taken after 20h of incubation with Alamar Blue. Optical density is adjusted relative to the average 
of 3 media controls. Significance between genotypes based on 2 tailed t-test, significance between time points 
based on one-way ANOVA; * = p<0.05, ** = p<0.01, *** = p<0.001, **** = p<0.0001 
In the initial assay, while the optical density did increase with greater culture time, the difference 
between these time points was not significant for either initial cell density. This was unexpected, as 
longer culture times might be expected to produce greater changes in cell density. Given that very 
little change in confluence was observed for both culture densities at each time point, this suggested 
that the MTFs grow more slowly at lower densities. To further test this, the growth assay was repeated 
with greater initial cell densities as described above. Here, although significant increases in optical 
density were observed between some time points for the 5000 cell cultures, the later time points 
showed no significant increases in optical density (Figure 38A), while the 10000 cell cultures showed 
no significant changes in optical density whatsoever over 4 days (Figure 38B). Furthermore, the 15000 
cell cultures showed an initial significant increase in optical density followed by a significant decrease 
(Figure 38C). Together with the observations of these cultures, this suggests that the 10000 and 15000 
cell cultures rapidly reached confluence within the wells, while the 5000 well cultures showed strong 
initial growth which had begun to plateau by the end of the assay. This is supported by the visual 
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inspections of each well on each day (data not shown). However, save for a single significant reduction 
in the optical densities of the 15000 cell KO cultures at 22h, no significant difference was observed 
between the Wt and KO genotypes at any cell density tested (Figures 38A, 38B and 38C), indicating 
that Malat1 KO has no effect on fibroblast growth rates over this period of time. 
In order to further assess any effects of Malat1 KO on fibroblast growth over a longer period of time, 
one Wt and one Malat1 KO MTF culture were maintained for as long as possible, with each passaged 
at around 70-80% confluence and visually inspected daily to determine any differences in cell growth 
and proliferation. Although the two cultures showed similar rates of growth initially, by passage 6 (P6) 
the Malat1 KO cells showed a noticeably reduced growth rate compared to the Wt cells, showing a 
larger, more spread out morphology associated with senescence (data not shown). Furthermore, 
while the Wt cultures were reliably maintained up to P10 before showing substantial cell death and 
the fore mentioned ‘fried egg’ senescent morphology at around P12, the KO cultures initially grew 
only to P8 before displaying arrested culture growth and senescent morphology (data not shown). 
However, inspection of this culture later showed patches of strong cell growth, more similar to the Wt 
cultures at this timepoint, and on further passage these cells were maintained up to P12 by the end 
of the experiment. This indicates that Malat1 has some effect on cell growth, senescence and cell 
cycle progression in MTFs over longer culture times.   
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Discussion 
In this study we found some evidence of Malat1 regulating some of its surrounding genes, as well as 
other RNA binding genes, in a cell type specific manner in CD4+ T cells, with some regulation of Malat1 
neighbouring genes also observed in mouse tail fibroblast (MTF) cultures. Additionally, we observed 
some residual expression of Malat1 in stimulated CD4+ cultures, while our MTF cultures showed more 
rapid senescence and reduced growth and proliferation in the Malat1 KO cells after 5 passages. 
Stimulation of primary and immortalised CD4+ T cells produces different significant 
changes in Malat1 expression 
The differing expression changes in Malat1 observed upon stimulation of primary and immortalised 
CD4+ T-cell lines indicate that the two sets of cells show different functional responses of Malat1 to T 
cell receptor activation, either by CD3/CD28 antibody stimulation or by T cell receptor crosslinking by 
PHA/PMA or ConA. This may be ascribed to differences in the signalling responses produced by each 
system of stimulation – while ConA and PMA/PHA are demonstrated to induce proliferation of T cell 
lines, stimulating protein kinase C (PKC) activation and an influx of Ca2+ into the cytoplasm, studies 
have shown these signals to be produced via different mechanisms for ConA and CD3/CD28 activation 
(Kay 1991, Pang et al 2012). Furthermore, while PHA has been demonstrated to bind to and crosslink 
the T cell receptor/CD3 complex (Kay 1991), triggering downstream T cell receptor signalling, Jurkat 
cells have been recorded to show several differences in downstream T cell receptor signalling from 
primary human cells. This includes exaggerated Ca2+ signalling and a more limited range of cytokine 
production due to hyperphosphorylation and increased activation of several downstream signalling 
kinases, including several involved in activation of PKC (Bartelt et al 2009). As such, although both 
CD3/CD28 and ConA stimulation promote proliferation of CD4+ T cells, the distinct signalling pathways 
involved in each would likely have differing effects on Malat1 levels, particularly as the significant 
expression changes observed in our stimulated primary cells indicated Malat1 to be regulated by T 
cell receptor signalling (Figure 20B). Stimulating further cultures of Jurkat and EL4 cells with the 
CD3/CD28 protocol used for the primary cell cultures and assessing Malat1 expression with further 
qPCRs would allow this possibility to be further assessed. 
As mentioned above, in both our primary CD4+ experiments and in previous transcriptomic studies 
(Stubbington et al 2015), stimulation of CD4+ cultures via T cell receptor activation significantly 
reduced Malat1 expression, indicating that T cell receptor activation and subsequent downstream 
signalling regulate expression of Malat1. Such regulation of Malat1 could be further evaluated by 
chromatin or RNA immunoprecipitation to test for association of the Malat1 genomic locus with 
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downstream T cell signalling factors, such as T bet, GATA-3 or members of the Jnk signalling pathway 
(Hu et al 2013, Yang et al 1998), as would testing for any effects of knockdown of these T cell signalling 
factors on Malat1 expression with and without T cell stimulation. Although both IFNγ and IL-4 showed 
significant changes in expression in the KO cells from Malat1 Th0 cultures (Figures 18A and 19A), 
suggesting a possible function for Malat1 in regulating expression of cell type specific cytokines in 
CD4+ Th0 cells, the minimal expression of both cytokines observed in this CD4+ cell type make the 
functional relevance of these results difficult to judge. Furthermore, while the Th1 and Th2 cultures 
showed differing expression levels of IFNγ, IL-4 and IL-10 respectively in Malat1 KO cells compared to 
Wt on a more substantial scale (Figures 18A, 19A and 20A), these differences were not significant on 
either day 4 (p = 0.41, p = 0.52, p = 0.08) or day 6 (p = 0.07, p = 0.06, p = 0.65), possibly due to the low 
sample numbers used for expression analysis of these cytokines. As such, further qPCR or ELISA 
analysis of IL-4, IL-10 and IFNγ expression in Malat1 KO CD4+ cells would be advisable to better 
evaluate if the lncRNA has some function in regulating these cytokines.  
Malat1 KO cells show some residual expression of Malat1 
The reduced expression of Malat1 in the stimulated Wt CD4+ cultures compared to naïve cells was 
consistent both with previous data from this research group (Hewitson, unpublished) and with 
transcriptomic data from mouse CD4+ cells, as was the similarly reduced expression of Neat1 in these 
cultures (Stubbington et al 2015). Furthermore, both Scyl1 and Map3k11 showed similar decreases in 
expression in stimulated CD4+ T cells in the data from Stubbington et al (2015) to that observed in our 
day 4 cultures (Figures 24B and 25B). While the day 6 cultures did not show the same significantly 
lower expression for these genes, our data indicates this to be due to differences in the response of 
the two day 6 culture sets to stimulation, rather than a definite change in regulation of these genes in 
the day 6 cultures. Notably, although the day 4 Th2 KO cultures showed similarly reduced Malat1 
expression compared to the other day 4 cultures (Figure 21A), our statistical analyses showed this 
difference to be non-significant, highlighting both the need for further replicates for greater reliability 
and that the current analysis of our results should be considered carefully. 
While the residual expression observed in the Malat1 KO cells from stimulated CD4+ cultures might 
reflect an increase in primer dimer amplification with T cell activation and differentiation, this is 
unlikely given both the similarly low Ct values observed in the Malat1 KO fibroblasts (Table 6) and the 
greatly reduced primer dimer peaks observed with lower Ct values in the naïve Malat1 KO cells (Figure 
14). Such residual expression, though unexpected, is consistent with data from the study that 
generated the Malat1 KO system used in these experiments – in this study, some residual expression 
of a 3.2kb transcript was observed in brain tissues from Malat1 KO mice, which was thought to reflect 
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a truncated transcript from the 3’ end of the gene expressed through activation of an internal 
promoter sequence in the gene (Figure 38). This suggestion was also proposed by Zhang et al (2012), 
who observed some slight residual expression of mascRNA in Malat1 KO brain samples and suggested 
that this reflected activity of a brain specific promoter upstream of mascRNA, i.e. within the 3’ end of 
the Malat1 sequence. This hypothesis is also consistent with a separate study of overexpression of 
Malat1 fragments, which indicated Malat1 to have a 3’ functional motif with key biological functions 
in cell migration and proliferation (Xu et al 2010). 
As the Malat1 qPCR primers used for the qPCR expression analysis amplify within the region thought 
to be expressed in the truncated transcript observed by Nakagawa et al (2012) (Figure 39), this 
truncated expression may be occurring in the stimulated CD4+ and MTF knockout cultures, with T cell 
receptor signalling stimulating expression from the internal Malat1 promoter sequence. However, 
primer dimer amplification remains a possibility, and as such would need to be tested in the fibroblasts 
and stimulated CD4+ cultures by using either further melting curve analysis or gel electrophoresis to 
assess the size of the product observed in these KO cells. Additionally, Nakagawa et al (2012) found 
no residual expression in mouse embryonic fibroblast (MEF) samples, which contradicts the results 
from the MTF samples. While this may reflect differences in fibroblast phenotype, as some studies 
have shown differences in gene expression between fetal and adult fibroblasts in response to stimuli 
such as wounding and tissue engineering protocols (Tang et al 2014), further analysis of the Malat1 
KOs would be required to confirm this, possibly by further qPCRs using primers at either the 5’ or 3’ 
end of the gene. 
 
Figure 39: Simplified diagram of the Malat1 locus, showing the relative positions of the truncated transcript 
identified by Nakagawa et al (2012) and the region amplified by the qPCR primers used in this study. 
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Neat1, Scyl1 and Map3k11 show regulation by Malat1 in specific cell types 
Based on the expression analysis from CD4+ and fibroblast cultures of both Wt and Malat1 KO 
genotypes, Malat1 does appear to regulate expression of Neat1, Scyl1 and Map3k11, but only in 
specific cell types or conditions. Although our results differ between the two culture time points, with 
significantly altered surrounding gene expression in Th0 and Th1 cultures only on days 4 and 6 
respectively (Figures 40B and 40F), this is likely due to the effects of expansion of the CD4+ cultures in 
IL-2 after day 4. While application of IL-2 has been strongly associated with increased T cell growth 
and survival in vitro, and thus is commonly used for prolonged in vitro CD4+ culture, it has also been 
found to have a key role in T helper cell differentiation, activating expression of downstream cytokine 
receptors and signalling proteins to modulate production of Th1 and Th2 effector cytokines (Hedfors 
and Brinchmann 2003, Liao et al 2011). Specifically, activation of STAT5 by IL-2 induces expression of 
IFNγ and IL-12Rβ2 during Th1 differentiation (Shi et al 2008, Liao et al 2011) and expression of IL-4 
and IL-4Rα in Th2 cells (Cote-Sierra et al 2004, Liao et al 2008). As such, given the apparent effects of 
T cell receptor signalling on Malat1 expression observed in these cultures, it is likely that the addition 
of IL-2 at day 4 promotes further Th1 and Th2 differentiation of the in vitro CD4+ cultures, and this 
heightened Th1 and Th2 signalling in turn alters CD4+ cell type specific expression and activity of 
Malat1. Given the differing directions of expression change observed at days 4 and 6 for both Scyl1 
and Neat1, this effect of IL-2 stimulation is more likely to account for the differences in significance 
than any statistical error arising from the differing sample sizes at each culture time – however, further 
sampling of primary CD4+ cultures at the day 4 time point would be required to confirm this. 
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Figure 40: Simplified diagram of the relative locations of Malat1 and the surrounding candidate genes 
 
 Malat1 Neat1 Scyl1 Map3k11 Tigd3 
Naïve 0.00025*** 0.431**** 1.184** 1.008 1.114 
d4 Th0 0.0281* 0.725* 2.738* 0.729 1.231 
d4 Th1 0.0222* 1.281 2.263 0.895 1.348 
d4 Th2 0.0197 0.778 2.312 1.276 0.741 
d6 Th0 0.00329**** 0.695 0.922 0.833 0.998 
d6 Th1 0.00797** 0.729* 0.745* 0.708* 1.928 
d6 Th2 0.00554*** 0.442 0.753 0.620 1.173 
Fibroblasts 0.00344** 1.037 1.690* 1.624 1.178 
 
Table 8: Summary of relative expression of Malat1 and surrounding genes in Malat1 KO cultures, expressed as 
a proportion of Wt expression averaged for each CD4+ cell type and fibroblast cultures. Significant differences 
from Wt are highlighted in bold based on 2 tailed T-tests: * = p<0.05, ** = p<0.01, *** = p<0.001, **** = 
p<0.0001 
For Neat1, these CD4+ expression results are consistent with some previous data on its interactions 
with Malat1, as two independent Malat1 KO studies showed regulation of Neat1 by Malat1 (Zhang et 
al 2012, Nakagawa et al 2012), with Nakagawa et al (2012) demonstrating that such regulation 
occurred only in specific cell types such as MEFs or intestinal cells. However, Eiβmann et al (2012) 
tested Neat1 expression levels across a variety of tissues, including the liver, brain, intestine and colon 
tissues assessed by the other two studies, and observed no significant differences in Neat1 expression 
across any of them. While none of these studies looked specifically at lymphocytes or CD4+ T cells, 
these differing results highlight the current contrasts in the data concerning regulation by and function 
of Malat1. This discrepancy may be attributed to differences in knockout techniques – while Zhang et 
al (2012) and Nakagawa et al (2012) both utilised deletion or inactivation (respectively) of the Malat1 
transcriptional start site and recorded significant local effects of Malat1 KO, Eiβmann et al (2012) 
deleted the entire gene and observed no significant effects. This suggests that the effects of Malat1 
knockout on Neat1 levels observed by Nakagawa et al (2012) and Zhang et al (2012) are dependent 
on the Malat1 locus itself, rather than the loss of Malat1 transcription. Given the truncated Malat1 
transcript identified by Nakagawa et al (2012) in their knockout model, this might suggest aberrant 
binding of transcription factors to this truncated transcript, which in turn would affect transcription 
of Neat1. However, this could equally be due to differences in the gene knockout and expression 
analysis methods used in each study, and thus experiments comparing transcription factor binding at 
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the Malat1 locus in these 3 knockout models and Wt cells, possibly via chromatin 
immunoprecipitation, would be required to further assess this possibility. 
Notably, of our candidate genes, the two located closest to Malat1, Neat1 and Scyl1 (Figure 40), were 
most affected by its knockout across multiple CD4+ cell types. Though this might indicate that insertion 
of the knockout cassette disrupts expression of these nearby genes, Nakagawa et al (2012) tested for 
such effects on Neat1 expression in the original knockout study by comparing expression with 
knockout and antisense knockdown (KD) of Malat1. As both means of gene inactivation produced 
significantly reduced Neat1 levels, they concluded that the loss of Malat1 expression was responsible 
for the changes in Neat1 expression, rather than disruption by the LacZ knockout cassette. While this 
study did not look specifically at Scyl1 expression in the Malat1 KD cells, the gene might also be 
expected to show disrupted expression in the Malat1 KOs, particularly given similar disruption 
observed downstream from other knockout cassettes (Pham et al 1996). However, such disruption of 
expression by Malat1 knockout would be likely to produce more universal effects on Scyl1 levels 
across all CD4+ cultures – furthermore, the differing effects of Malat1 KO on Scyl1 expression in 
different cell types indicate a more specific regulatory effect to be responsible, rather than general 
disruption of expression near the Malat1 locus. As such, this increased effect of Malat1 KO on closer 
genes may indicate the presence of one or more cis regulatory elements near Malat1, with greater 
effects on genes in the immediate proximity than on more distal transcripts. This possibility could be 
further tested with qPCR analysis of more of the genes surrounding Malat1, particularly those located 
between the candidate genes tested here such as Ltbp3, Ehbp1l1 or Frmd8, and comparing the extent 
of Malat1 KO effects on genes at different distances from Malat1. 
Several mechanisms have been identified by which intergenic lncRNAs regulate their surrounding 
genes in cis, such as promoting formation of chromatin loops to allow interaction of enhancer and 
promoter sequences or increasing chromatin accessibility and Pol2 occupancy of nearby genes (Vance 
and Ponting 2014). While one of these mechanisms of in cis regulation may occur at the Malat1 locus, 
these mechanisms have been found to positively regulate local transcription rather than repress it. As 
such, this type of regulation would be inconsistent with our observed Scyl1 expression results, both 
with the significant upregulation observed with Malat1 KO in both fibroblast and CD4+ cultures and 
the diverging expression changes recorded in different CD4+ KO cultures. This varying effect of Malat1 
KO on Scyl1 expression in different CD4+ cell types is unlikely to be due to changes in expression 
between the various cell types – while Scyl1 expression did vary across CD4+ cell types both here and 
in previous data (Stubbington et al 2015), these differences did not correlate with the cell types which 
observed significant differences in Scyl1 levels between Wt and KO cultures. In addition, the 
interactome data of Engreitz et al (2014) found only a single direct interaction of Malat1 with the 
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ncRNA U1, with their results suggesting the rest to be indirect interactions of Malat1 with pre-mRNAs 
and active chromatin sites via association with splicing factors. As such, our Scyl1 expression data 
indicates an indirect, highly cell type specific form of regulation by Malat1, likely through the activity 
of cell type specific transcription factors. 
A more cell type specific form of in cis regulation by Malat1 would be targeting of cell type specific 
transcription factors to the Malat1 locus, with these factors subsequently interacting with nearby 
enhancer or promoter sequences to regulate surrounding gene expression. Such regulation would be 
consistent with the observed CD4+ cell type specificity, as a previous study identified distinct genomic 
profiles of active enhancer regions in Th1 and Th2 cells, with binding of acetyltransferase p300 to 
enhancers of lineage specific genes in both cell types and enrichment of binding motifs for lineage 
specific transcription factors at these enhancers (Vahedi et al 2012). This possibility is also consistent 
with earlier work on the Malat1 interactome, which observed only indirect interactions of Malat1 with 
other loci or mRNAs and, in particular, a strong indirect association of Malat1 with Scyl1 and a less 
strong association with Map3k11 (Engreitz et al 2014). Furthermore, such transcription factor binding 
would be consistent with the results of the initial Malat1 KO studies – as detailed earlier, the differing 
effects of various Malat1 KO systems on Neat1 expression indicate the Malat1 locus itself to have a 
greater effect on neighbouring gene expression than Malat1 transcription, and therefore suggest 
binding of transcription factors to the Malat1 gene influencing surrounding gene levels (Zhang et al 
2012, Nakagawa et al 2012, Eiβmann et al 2012). Such regulation could occur via the formation of 
chromatin loops, allowing interaction of the Malat1 bound factors with more distal genes such as 
Map3k11, and could be further assessed by using chromatin immunoprecipitation to compare binding 
of CD4+ T cell signals at both the Malat1 and surrounding gene loci between Wt and Malat1 KO 
cultures. 
Interestingly, our qPCR data showed evidence of neighbouring gene regulation by Malat1 in only 3 of 
the CD4+ cell types; naïve cells, the day 4 Th0 culture, and the day 6 Th1 culture (Table 8). Together 
with the apparent effects of T cell receptor signalling on Malat1 expression and the possibility of 
transcription factors at the Malat1 locus regulating the surrounding genes, this suggests regulation of 
these genes via binding of lineage specific downstream signalling proteins to the Malat1 locus within 
these CD4+ cell types. Given that the Th1 specific regulators STAT4 and T-bet have been observed to 
bind to and regulate expression of numerous lncRNAs, with STAT4 and STAT1 also identified as key 
regulators of enhancer region activation in Th1 cells (Hu et al 2013, Vahedi et al 2012), these 
transcription factors would be likely candidates for such cell type specific regulation of the Malat1 
locus. Additionally, transcription factors found to be specific to naïve and Th0 CD4+ cells, such as those 
identified by Kanduri et al (2015) or Spurlock et al (2017) via transcriptional profiling, could also be 
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worth assessing as candidates for Malat1 regulation. Downstream effectors of STAT5A, STAT5B and 
other members of the Jnk signalling cascade would also be worth investigating further, as these factors 
were found to be activated by IL-2 stimulation of CD4+ cells and have roles in regulating Th1 
differentiation (Gesbert et al 2005, Liao et al 2011), and thus would be consistent with the day 6 
specific expression changes observed here. Possible interactions between Malat1 and these CD4+ 
regulatory proteins could be tested via chromatin immunoprecipitation (ChIP) analysis to test for 
binding of the transcription factors to the Malat1 locus or surrounding enhancer sequences and gene 
loci as described above, and to compare any such binding between the different CD4+ cell types. 
Given that previous Malat1 interactome studies indicated active gene expression to be required for 
Malat1 association at the genomic locus (Engreitz et al 2014), this apparent regulation of Neat1, Scyl1 
and Map3k11 suggests these genes to have potential functions in naïve, Th0 and Th1 CD4+ subtypes. 
For Scyl1, this is consistent with previous data on its role in Golgi body morphology (Burman et al 
2010) – IL-2, a characteristic Th1 cytokine, is thought to be secreted via the Golgi apparatus (Duitman 
et al 2008), and as such active expression changes in components of this cellular apparatus might be 
expected in the Th1 CD4+ cultures. Similarly, other Map kinases and members of the Jnk signalling 
pathway have been found to have key functions in the function and differentiation of Th1 cells, 
correlating with the significant effects of Malat1 KO on Map3k11 in the day 6 Th1 cultures specifically 
(Yang et al 1998, Dong et al 2000). While no such CD4+ cell specific functions have been identified for 
Neat1, human CD4+ knockout models of the gene have shown enhanced HIV infection due to reduced 
splicing of viral RNAs by the paraspeckles, and thus indicate a role for Neat1 in antiviral immunity of T 
helper cells (Liu et al 2018). However, these potential functions are contrasted somewhat by our qPCR 
expression data, as, aside from the significant downregulation upon T cell activation, no significant 
expression changes were observed in all 3 genes between the Th0, Th1 and Th2 cultures at any 
timepoint recorded (Figures 22B, 24B and 25B). Given these conflicting possibilities, assessing the 
potential functions of these surrounding genes in the naïve, Th0 and Th1 CD4+ cell types might be 
prudent, possibly by using either KO or antisense knockdown models of each gene to compare CD4+ 
culture growth and survival while using further qPCR analysis to assess expression of characteristic 
Th1 and Th2 cytokines in these cells.  
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Las1l and U2af1 are regulated in trans by Malat1 in specific CD4+ cell types 
The lack of significant effect of Malat1 KO on expression of the majority of the RNA binding proteins 
tested here is consistent with existing data – while Malat1 has been suggested to be essential to 
alternative splicing occurring in the nuclear speckles (Tripathi et al 2010), knockout studies showed no 
effect of Malat1 KO on pre-mRNA splicing and nuclear speckle structure (Zhang et al 2012). 
Furthermore, while Engreitz et al (2014) found these RNA binding proteins to bind indirectly to 
Malat1, this does not necessarily indicate regulation of these genes by the lncRNA. However, while 
some substantial expression differences were observed between the naïve Wt and Malat1 KO cultures 
for these RNA binding protein genes, such as increased U2af1 expression and reduced Hist1h4a and 
Ddx23 expression in the naïve KO cells, none of these differences could be assessed for significance, 
given that only 1 Wt and 1 Malat1 KO naïve cell sample was tested for each of these RNA binding 
proteins. Similarly, while substantial expression differences were observed across these RNA binding 
proteins between the naïve and stimulated CD4+ cultures, the significance of these results could not 
be confirmed with only 1 naïve cell sample. As such, further qPCRs would be required to better assess 
the significance of any observed expression differences across these cell types. 
Although further qPCR analysis would be required to test the significance of the observed CD4+ 
expression differences, the direction of these expression changes was unexpected. While the CD4+ 
transcriptomic data from Stubbington et al (2015) showed substantially reduced expression of all 
these RNA binding proteins in Th1 and Th2 cells compared to naïves, only U2af1 and Cpsf1 showed 
reduced expression in stimulated CD4+ cultures, while the others showed either little expression 
change or substantially increased expression in these cultures. This contrast in expression data may 
be due to differences in technique – while both experiments used the same protocol for CD4+ 
stimulation of Th1 and Th2 cell cultures, Stubbington et al (2015) determined expression values using 
microarray analysis, as opposed to the qPCR analysis used here. As such, given that Ddx23 and Las1l 
both show evidence of alternative splicing (Rengasamy et al 2017, Joo et al 2013), it may be that the 
primer sets from both studies bind preferentially to different splice variants of each gene, with the 
reduced expression of one splice variant during T cell activation leading to concurrently increased 
expression of another. However, not all genes showing different expression changes from Stubbington 
et al (2015) have alternative splicing variants – as such, while this splice variant explanation is possible, 
particularly given the intron spanning qPCR primer pairs used in this study, it would not account for 
all differences in CD4+ expression patterns between this study and previous data. As such, further 
qPCRs and statistical analysis would be crucial to better assess these conflicting data sets, while any 
differences in splicing variant expression and primer amplification between the two studies could be 
further tested via qPCRs with primers specific to both spliceforms of each gene. 
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Some evidence of cell type specific in trans regulation of these RNA binding proteins by Malat1, 
specifically U2af1 and Las1l, was observed our CD4+ cultures. As previous studies have indicated 
Malat1 localisation to genes to be dependent upon active transcription of those genes (Engreitz et al 
2014), this indicates some cell type specific role for U2af1 and Las1l in CD4+ cultures. This is consistent 
with a study showing a key role of U2af2, regulated by U2af1, in coordinating T-cell activation, as well 
as transcriptomic studies showing strong association of Malat1 with numerous pre-mRNA splicing 
factors (Whisenant et al 2015, Chen et al 2017). Furthermore, although previous Malat1 KO studies 
found no significant changes in splicing factor expression or localisation or in global pre-mRNA splicing 
patterns (Zhang et al 2012, Nakagawa et al 2012), Zhang et al (2012) did observe significant changes 
in a handful of exons in both brain and liver tissues, highlighting the possibility of Malat1 having 
specific effects on alternative splicing factors in our CD4+ T cell cultures. This could be further 
investigated by looking at the effects of U2af1 knockout on expression of characteristic Th2 cytokines, 
such as IL-4 and IL-10, as well as comparing alternative splicing of mRNAs known to interact with 
U2af1.  
While no specific function has been observed for Las1l in CD4+ T cells, as a subunit of the nucleolar 
rRNA processing complex, it has a ubiquitous function in ribosome biogenesis and cell proliferation, 
specifically in G1 to S phase progression (Castle et al 2010), and has been found to interact with Malat1 
at both the protein and pre-mRNA stages (Chen et al 2017, Engreitz et al 2014). In addition, earlier 
research showed T cell stimulation to increase ribosomal protein and RNA synthesis, with other rRNA 
processing factors such as RRS1 upregulated by the ERK MAPK pathway (Asmal et al 2003). Given this 
data, it is possible that Las1l is similarly upregulated in our stimulated CD4+ cultures, with the apparent 
in trans regulation of Malat1 specifically in day 4 Th0 cells potentially indicating either cell type specific 
targeting of the lncRNA to Las1l or regulation by Malat1 during T cell activation being suppressed by 
subsequent Th1 or Th2 specific signalling. However, given the very low expression of Las1l observed 
across all CD4+ cell types (Table 7), this possibility should be considered carefully, as such low levels of 
Las1l would be unlikely to have functional relevance. As such, using KO or knockdown models of Las1l 
to further assess the genes role in CD4+ T cells, as suggested for the genes surrounding Malat1, might 
be prudent to follow up on these initial results. Similarly, any effects of increased Las1l expression in 
these CD4+ cultures on rRNA processing could be further investigated by comparing levels of the 12S 
and 32S rRNAs in our Wt and Malat1 CD4+ cultures, as siRNA knockdown of Las1l has been found to 
substantially alter levels of these two ribosomal subunit components (Castle et al 2010).  
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Malat1 KO affects cell proliferation of long term fibroblast cultures 
Observation of the MTF cultures over longer time periods indicated that Malat1 affected the growth 
and proliferation of these cells after 5 passages (P5), with Malat1 KO cultures beyond this point 
showing less frequent divisions and with many cells showing a larger, more spread out ‘fried egg’ 
morphology characteristic of senescent cells. Such effects on proliferation are consistent with Malat1 
data from numerous cell lines, where knockdown or silencing of the lncRNA in gastric, cervical or 
breast cancers led to significant G0/G1 cell cycle arrest and reduced cell growth and proliferation 
(Wang et al 2014, Guo et al 2010, Zhao et al 2014). Furthermore, a previous paper assessing Malat1 
depletion in human dermal fibroblasts (HDFs) observed similar G1 cell cycle arrest and senescent 
morphology in their cultures upon antisense knockdown of the lncRNA, with significant 
downregulation of numerous proteins involved in G1/S phase transition (Tripathi et al 2013). As such, 
the senescent morphology and reduced proliferation of the Malat1 KO MTF cultures could occur 
through the mechanism proposed in this earlier study, with Malat1 depletion leading to altered 
expression and alternative splicing of the transcription factor B-MYB and subsequent expression 
changes in the cell cycle genes regulated by this factor inhibiting mitotic progression (Tripathi et al 
2013). However, this data only represents a preliminary set of results, particularly given the lack of 
significant difference observed in shorter term Alamar Blue assays (Figure 38). As such, these findings 
would need to be further investigated before such interpretations are made, possibly by using qPCRs 
to compare the expression of B-MYB and other associated cell cycle genes in Wt and Malat1 KO MTF 
cultures, or the presence of senescence markers such as oxidative stress and shortened telomeres. 
Alternatively, supplementing Malat1 KO cultures with cell cycle factors associated with G1/S or G2/M 
phase transition, such as FOXM1, would further assess these findings by testing for a growth 
phenotype more similar to the Wt MTF cultures.  
An alternative explanation for the MTF culture growth was also suggested by the data of Tripathi et al 
(2013), which observed increased activity of p53 upon Malat1 depletion in various cell lines. Given 
both the known function of p53 as a DNA damage response regulator (Williams and Schumacher 2016) 
and the importance of cell cycle checkpoint pathways, such as those disrupted by Malat1 depletion, 
in regulating DNA repair mechanisms (Branzei and Foiani 2008), Malat1 has been suggested to have a 
role in regulating DNA damage repair. As such, it may be that this process is impaired in the Malat1 
KO MTF cells, leading to the more rapid accumulation of DNA damage and subsequently more rapid 
senescence observed by P5. This might also be consistent with the increased proliferation of Malat1 
KO cells observed after P9 – as this growth was initially observed in patches among no clear growth in 
the other cells, this suggests individual MTFs to have acquired random mutations which restored 
similar proliferation to Wt cultures, possibly by restoring Malat1 expression or knocking out 
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expression of another gene such as p53 which ablates the Malat1 KO phenotype. As with the earlier 
explanation, however, this is based on initial findings, and would require further experimental 
verification to be fully assessed. 
Conclusion 
In summary, our data indicates a regulatory function for Malat1 in naïve, Th0 and Th1 CD4+ T cells, 
possibly in cis via transcription factor binding at the Malat1 locus acting on nearby enhancer or 
promoter sequences. However, given both the variance observed between sample sets and the 
relatively low sample size, particularly for the studies of RNA binding proteins, further analysis would 
be required both to confirm the significant expression changes observed here and to further assess 
some substantial changes whose significance could not be determined. Assessing expression of these 
genes in Wt and Malat1 KO cultures of other CD4+ cell types, such as Th17 and Treg cells, would also 
be advisable to more clearly determine the effects of CD4+ T cell receptor signalling and activation 
pathways on Malat1, as well as the expression and regulation of our candidate genes in response to 
such T cell signalling. Finally, our growth data from mouse tail fibroblast cultures correlates with 
known functions of Malat1 in cell growth and proliferation, and may indicate regulation either of cell 
cycle gene activity or of DNA repair pathway components by the lncRNA.  
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